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Newts have an amazing ability to regenerate lost structures and injured tissues. 
After a complete transection injury, which paralyzes the lower half of the animal, the 
newt spinal cord regenerates in as little as 4 weeks and re-establishes controlled 
movement. We have developed new methods of visualizing the cellular and molecular 
events of spinal cord regeneration and have used these to define six stages of axon 
regeneration. We also find that axon regeneration appears to be enabled, in part, because 
the lesion environment is permissive. The extracellular matrix is made up of canonically 
permissive and inhibitory proteins, but it remains loose and is not dense like it is in 
mammalian lesions. Meningeal cells and glia are most closely associated with 
regenerating axons and, instead of forming barriers to axon regeneration as they do in 
mammals, they appear to assist the regenerative process. 
Amputated limbs are regenerated in about 7 – 10 weeks. After amputation, mature 
cells de-differentiate and form a proliferating pool of progenitor cells under the 
amputation plane called the regeneration blastema. The blastema then organizes itself 
into a new limb. Little is known about what molecular factors drive blastema formation 
and growth. We have identified a novel newt chemokine, NvCXCL, that is highly 
upregulated during limb regeneration and may play a role in this process. NvCXCL is 
expressed in de-differentiating tissues and the blastema, stimulates cells of mouse 
 iv 
fibroblastic and myoblastic cell lines to proliferate, and mildly induces the mouse 
fibroblasts to migrate, although not in a directed fashion. 
 This work establishes a detailed baseline of the events occurring during spinal 
cord regeneration and identifies a novel chemokine that may be involved in the formation 
and growth of the limb blastema. Further insights into the mechanisms driving limb and 
spinal cord regeneration will be greatly aided by the development of more powerful 
genetic tools. If the dream of regenerative medicine is to become a reality, it is imperative 
that we learn all we can about how nature has already derived a solution for regenerating 
injured structures and organs in this exceptional animal. 
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The ability some animals have to scarlessly regenerate flesh wounds and complex 
structures such as limbs, eyes, spinal cords and even heads after they are lost or damaged 
rarely fails to invoke awe and stimulate the imagination. If only we could learn their 
secrets, maybe someday we too could regrow a limb or walk again after a spinal cord 
injury (SCI). Perhaps in the future doctors will be able to, as shown in the popular Star 
Trek television series, wave a device over an injured area that stimulates our own cells to 
flawlessly heal the damage. Such technology would make surgical interventions, cell-
replacement therapies, and prosthetic devices appear crude and obsolete. While this 
reality may be relegated to the realm of science fiction for now, it is a seemingly 
impossible dream that, like the dream of flying once was, will not be extinguished. 
1.1 Basic principles of regeneration 
 Regeneration, in a broad sense, is the ability to replace lost or damaged tissues to 
the extent that the restored tissues resemble and function as well as the original. This is in 
contrast to fibrotic wound healing, which walls off injuries and repairs them with scar 
tissue. This type of healing does not restore tissues to their original form and function 
(reviewed in Harty et al., 2003). For regeneration to occur, two principal components are 
needed: a source of cells and a genetic program that can control the cells and direct them 
to reconstruct the missing tissues. In other words, regeneration requires building blocks 
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and a blueprint. Stem cells, progenitor cells, and/or differentiated cells can be used as the 
cell source, and regeneration can take place in the presence or absence of significant cell 
proliferation.  
When stem or progenitor cells are used as the cell source, injury induces these 
cells to proliferate and produce undifferentiated progeny that are capable of re-forming 
all of the lost cell types and tissues. Epithelial tissues in mammals are regenerated in this 
way if the damage is not so extensive that it eliminates the stem cells (Blanpain et al., 
2007). Differentiated cells can be used similarly in that they can be induced to de-
differentiate into progenitor cells that collectively can re-form all of the lost cell types 
and tissues. If the de-differentiated cells and/or stem cell progeny collect under the injury 
site and form a regeneration blastema, a structure that has self-organizing properties 
(reviewed in Nye et al., 2003), then the regenerative process is termed epimorphosis 
(reviewed in Brockes et al., 2001). Regeneration in planarians (freshwater flatworms) and 
regeneration of limbs and tails in salamanders occurs via epimorphosis. In planarians, the 
blastema is formed by stem cell progeny (reviewed in Reddien and Sanchez Alvarado, 
2004). In salamanders, it is formed by a combination of stem cell progeny and de-
differentiated cells (Morrison et al., 2006; Kragl et al., 2009).  
More rarely, differentiated cells can be used to replace or repair tissues in the 
absence of proliferation in a process termed morphallaxis. The term indicates that tissues 
are repaired via a re-modeling process instead of a re-building from scratch, as is the case 
with epimorphosis (reviewed in Brockes et al., 2001). Regeneration in hydra (a 
freshwater polyp) occurs via morphallaxis. When the head is amputated, cells in the body 
column are re-modeled, or trans-differentiated, into head cells. This process does not 
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require proliferation (reviewed in: Bode, 2003; Bosch, 2007). Regeneration of axons in 
the nervous system can also be thought of as a type of morphallaxis. In this example, an 
axotomized neuron does not have to proliferate or trans-differentiate into another type of 
cell in order to restore form and function. It simply needs to be able to survive, re-grow 
an axon and re-establish functional synapses with appropriate targets.  
Cells may be mobilized for regeneration primarily by one, or more likely a 
combination of these processes. What is essential, though, is that cells have the capacity 
to be mobilized. In other words, cells need to have enough flexibility or plasticity to be 
able to do what is required for regeneration (Brockes and Kumar, 2002; Odelberg, 2005). 
After cells are mobilized, they need to be guided to re-form the missing parts. A 
sequence of events needs to be set in motion that can reliably reproduce the required form 
and function. Given that genetics governs the initial development of proper form and 
function and that regeneration of a structure often resembles its original development, it 
is thought that regeneration proceeds as a recapitulation of, or a variation on, 
developmental genetic programs (Brockes et al., 2001). For example, developing limb 
buds and regenerating limb blastemas progress through similar stages and utilize 
common molecular pathways to produce a functional limb (Muneoka and Bryant, 1982; 
Nye et al., 2003). In fact, it is thought that regenerative abilities are greater in animals 
that never stop growing, that is, in animals that exhibit indeterminate growth, because 
their developmental programs are always active (Holder and Clarke, 1988). 
1.2 Regeneration in animals 
 All animals have some capacity for regeneration, although the extent tends to 
decline as the complexity of the animal increases. Invertebrates such as hydra and 
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planarians have such extensive regenerative abilities that they are said to be immortal 
under the knife. They can regenerate all of their tissues and organs, including their heads 
(reviewed in: Bode, 2003; Reddien and Sanchez Alvarado, 2004; Bosch, 2007). 
Vertebrates are more limited in their regenerative capacities with the more “primitive”, 
cold-blooded classes having higher regenerative potentials than the more “advanced”, 
warm-blooded classes. For example, many fish, amphibians and reptiles can regenerate 
complex structures such as limbs or tails, whereas regeneration in birds and mammals is 
much more limited. Mammals have only a modest capacity to regenerate epithelial, bone, 
and muscle tissues, as well as digit-tips and organs such as the liver (Sanchez Alvarado 
and Tsonis, 2006). 
Regenerative abilities also tend to decline as a function of developmental age in 
individuals (Bryant et al., 2002; Ferretti et al., 2003; Carlson, 2007). For example, frogs 
can regenerate limbs and spinal cords before metamorphosis, but lose this ability after 
metamorphosis (Dent, 1962; Forehand and Farel, 1982; Beattie et al., 1990). Chicks and 
many mammals are able to regenerate limbs and spinal cords during development, but 
lose this ability before or shortly after birth (Bregman and Goldberger, 1983; Wanek et 
al., 1989; Kunkel-Bagden et al., 1992; Hasan et al., 1993; Kostakopoulou et al., 1996; 
Saunders et al., 1998). This may occur because, as noted above, genetic programs 
required for regeneration are irreversibly shut off as the animal matures. 
The observation that regenerative abilities tend to decline as the complexity of 
species increases and an individual’s development proceeds suggests that regeneration is 
an ancestral ability that was lost during the course of evolution (Brockes et al., 2001; 
Sanchez Alvarado and Tsonis, 2006). Thus, understanding how regeneration occurs in 
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more primitive species may enable us to unlock latent regenerative potentials in our own 
species. Invertebrate model systems are powerful tools because they are simpler 
organisms, making it easier to dissect the basic molecular and cellular principles of 
regeneration. If, however, we are ever to achieve the goal of being able to regenerate 
complex structures such as limbs and spinal cords in mammals, and ultimately in 
humans, it is equally imperative that we learn about how these complex structures 
regenerate in cold-blooded vertebrates. Because salamanders are regarded as the 
“champions” of vertebrate regeneration (Brockes et al., 2001), a salamander was the 
model system of choice for the studies presented herein. 
1.3 Regeneration in salamanders 
Salamanders (Urodeles) represent one of the three orders of amphibians, the other 
two being Anura (frogs and toads) and Gymnophiona (legless amphibians). Two main 
families of salamanders are commonly studied in the regeneration field: the mole 
salamanders (Ambystomatidae) and the newts (Salamandridae). More specifically, the 
axolotl (Ambystoma mexicanum) is the mole salamander commonly studied, and the 
newts commonly studied are those indigenous to various regions such as the Eastern newt 
(Notophthalmus viridescens), the Japanese newt (Cynops pyrrhogaster), and the 
European newt (Pleurodeles waltl).  
Newts are aquatic, tailed amphibians. They hatch from eggs as aquatic larvae and 
after a few months undergo metamorphosis, during which they lose their gills, develop 
lungs and legs, and become terrestrial juveniles. One to 3 years later, they undergo a 
second metamorphosis, become sexually mature, and return to the water in their adult 
form. The Eastern newt has a lifespan of about 12 to 15 years. In contrast, axolotls are 
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said to be neotenic larval salamanders because they never complete the first 
metamorphosis. They develop legs and become sexually mature, but retain larval 
characteristics, such as gills, throughout their lives (Brockes and Kumar, 2005). 
 Newts and axolotls both have amazing regenerative abilities, but because newts 
complete metamorphosis and therefore may represent the most mature form that can 
regenerate, we preferred to study them so that lessons learned might be more applicable 
to the problem of regeneration in adult humans. An adult newt can regenerate its limbs 
(Brockes, 1997), tail (Iten and Bryant, 1976), jaw (Ghosh et al., 1994), retina (Mitashov, 
1996), lens (Eguchi et al., 1974), portions of its heart (Oberpriller and Oberpriller, 1974) 
and even its spinal cord (Piatt, 1955).  
Work presented in this dissertation focuses primarily on spinal cord regeneration, 
but also touches on limb regeneration in the Eastern newt, Notophthalmus viridescens. To 
reiterate, salamanders are the only vertebrates that can regenerate limbs as adults and the 
only order of tetrapod (four-limbed) vertebrates that can regenerate their spinal cords as 
adults. Fish can regenerate fins and their spinal cord as adults but do not have limbs 
(Zottoli et al., 1994; Becker et al., 1997; Akimenko et al., 2003). Frogs can regenerate 
their limbs and spinal cord, but not as adults: they lose the ability when they undergo 
metamorphosis (Dent, 1962; Forehand and Farel, 1982). 
1.4 Newt limb regeneration 
As mentioned above, newt limb regeneration is a prime example of epimorphic 
regeneration. It is completed in about 7 – 10 weeks and can be divided into three phases: 
wound healing (about 1 day), de-differentiation and blastema formation and growth (1 to 
3 weeks), and differentiation and morphogenesis (3 to 10 weeks) (Iten and Bryant, 1976). 
 7 
Immediately after amputation of a limb, epithelial cells migrate to cover the wound 
within 24 hours. This wound epidermis (WE) then thickens over the next few days to 
form an apical epithelial cap (AEC). As the WE thickens, cells from various tissues such 
as muscle, bone, and connective tissues de-differentiate and form a zone of immature 
mesenchymal cells under the AEC called the regeneration blastema. Muscle stem cells 
also contribute to the blastema. The blastema grows as de-differentiation proceeds and 
the blastemal cells divide. At about 3 to 4 weeks after amputation, de-differentiation and 
blastemal growth cease, and the blastema begins to develop into the new limb. Blastemal 
cells are patterned and re-differentiate to form all of the tissues of the limb such as 
muscle and bone.  
The regeneration blastema plays a central role in newt limb regeneration and is a 
special structure that “knows” what to regenerate. For example, a bicep blastema is 
programmed to regenerate an elbow, forearm, wrist and hand, whereas a forearm 
blastema is programmed to regenerate only a wrist and hand (reviewed in Brockes, 1997; 
Nye et al., 2003). Likewise, a leg blastema will regenerate a leg. While much research 
has focused on cellular processes associated with and required for blastema formation 
and growth, the molecular mechanisms involved are only just beginning to be discovered. 
It is known that the early blastema requires nerves (Singer and Craven, 1948) for its 
survival and that the late blastema requires communication with the AEC (Mescher, 
1976). Recent work has shown that Schwann cells in the nerve produce an anterior 
gradient protein (AG) that is sufficient to rescue blastemal survival and proliferation, and 
hence limb regeneration, in denervated limbs (Kumar et al., 2007). Much more work, 
however, is needed to determine what factors mobilize cells to produce this important 
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structure. To address this need, we performed a gene expression screen comparing genes 
expressed in intact and regenerating limbs and have begun to characterize one promising 
candidate that may play a role in cell proliferation and migration during limb 
regeneration. This is the topic of Chapter 2 of this dissertation.  
1.5 Spinal cord regeneration 
1.5.1 Spinal cord basics and requirements for  
functional recovery after SCI 
The spinal cord is part of the central nervous system (CNS). When viewed in 
cross section, it is made up of a central canal that is filled with cerebral spinal fluid and 
surrounded by ependymal cells. Grey matter containing neuronal cell bodies and 
astrocytes surrounds the ependymal cells, and white matter containing myelinated axon 
tracts surrounds the grey matter. The whole cord is wrapped by the three layers of the 
meninges: the innermost pia mater and its associated basal lamina, the arachnoid mater, 
and the outermost dura mater.  
The newt spinal cord histologically resembles the mammalian spinal cord. The 
main differences are that the newt spinal cord is smaller, has less grey matter, and its 
ependymal cells have the morphology of radial glia, the neuronal and glial progenitor cell 
of the developing mammalian neural cortex (Ferretti et al., 2003). Their radial processes 
extend to and maintain contact with the basal lamina of the pia mater. Therefore, newt 
ependymal cells are often referred to as radial ependymoglia or, more simply, 
ependymoglia (EG).  
The spinal cord contains motor neurons that send axons to muscles in the 
periphery, propriospinal neurons whose axons never leave the spinal cord, and long 
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distance projection axons that transmit motor commands from the brain to the motor 
neurons in the spinal cord and sensory information from the periphery to the brain. When 
the spinal cord is injured, motor and propriospinal neurons in the injury site may die, but 
the main reason why spinal cord injuries are so devastating is because long distance 
axons are damaged and the brain is disconnected from the entire spinal cord distal to the 
injury. When a long distance axon is cut, the distal part of the axon degenerates and is 
phagocytosed in a process called Wallerian degeneration, and the proximal part, the part 
that is still connected to the cell body, has the opportunity to re-grow if the cell body does 
not die (reviewed in Bradbury and McMahon, 2006). 
Therefore, to restore the bulk of the function lost after a spinal cord injury, new 
neurons do not necessarily need to be generated, but the following must be accomplished. 
1) Axotomized long-distance projection neurons must survive, and the extent of the 
damage must be minimized. 2) Surviving neurons must regenerate their axons through 
and beyond the injury site. 3) The regenerating axons must be guided to proper targets. 4) 
They must re-establish functional synapses with those targets. 5) They must be able to 
conduct action potentials. 6) The re-established synapses must be able to restore function. 
Thus, functional regeneration of axons can be thought of as a type of morphallaxis. New 
cells may be required to assist the process, but the critical component is the proper 
remodeling of the surviving neurons’ processes. In mammals, the first criterion is 
partially met in that some long distance projection neurons do survive the injury, but the 




1.5.2 Spinal cord injury in mammals and regeneration failure 
Axons fail to regenerate through and beyond a spinal cord injury site in mammals 
for two primary reasons: 1) adult CNS neurons, though they do have some capacity for 
growth (David and Aguayo, 1981), are intrinsically inefficient at re-growing an axon (Cai 
et al., 2001; Blackmore and Letourneau, 2006) and 2) the environment of the injured 
spinal cord is inhibitory for axon regeneration (reviewed in Silver and Miller, 2004). A 
variety of cell types near an SCI lesion react to create physical barriers to axon 
regeneration, such as a scar, glia limitans, and cystic cavities, as well as chemical 
barriers, such as an extracellular matrix (ECM) that is repulsive for axon migration. 
Chondroitin sulfate proteoglycans (CSPGs) are a major component of the inhibitory 
ECM (Davies et al., 1999; Tang et al., 2003), and though permissive proteins such as 
laminin (LM) (Busch et al., 2010) and fibronectin (FN) (Bundesen et al., 2003; Herrmann 
et al., 2010) are also expressed, overall the matrix is dense and does not promote growth 
cone motility (Condic and Lemons, 2002). Beyond the injury site, axon regrowth is 
inhibited by proteins expressed on degenerating myelin such as Nogo-A (Chen et al., 
2000), myelin associated glycoprotein (MAG) (McKerracher et al., 1994; Mukhopadhyay 
et al., 1994), and oligodendrocyte myelin glycoprotein (OMgp) (Wang et al., 2002). 
Axon regeneration can be modestly improved by a number of manipulations, including 
treatments that: enhance neuron-intrinsic growth potential, such as cyclic AMP injections 
(Qiu et al., 2002); degrade CSPGs, such as application of chondroitinase ABC (Bradbury 
et al., 2002); neutralize myelin inhibitors, such as application of function-blocking 
antibodies (Caroni and Schwab, 1988); or provide a bridge that does not contain 
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inhibitors, such as implantation of a peripheral nervous system bridge (David and 
Aguayo, 1981).  
Three of the cell types that create an inhibitory environment in the lesion are 
astrocytes, meningeal fibroblasts, and macrophages (reviewed in Silver and Miller, 
2004). Activated astrocytes become hypertrophic, meaning that they upregulate 
cytoskeletal proteins such as glial fibrillary acidic protein (GFAP) and their processes 
become thickened. Their hypertrophic processes wall off the injury and contribute to the 
formation of the barrier glia limitans between the cord and the injury site. Astrocytes also 
migrate into the injury site to contribute to the formation of a dense scar. Throughout all 
these activities, astrocytes secrete inhibitory CSPGs. Thus, the CSPGs are deposited in 
the scar, glia limitans, and in the spinal cord white matter in a gradient that increases as 
axons approach the edge of the lesion (Davies et al., 1999). Meningeal fibroblasts also 
invade the injury site, secrete high levels of ECM proteins including CSPGs, and 
participate in the formation of the scar and glia limitans. In fact, meningeal cells and 
astrocytes may communicate with each other to form the glia limitans (Bundesen et al., 
2003; Shearer et al., 2003). Activated macrophages invade the lesion to phagocytose 
debris, contribute to the formation of the scar as well as cystic cavities (Fitch et al., 
1999), and have even been shown to physically interact with axons to cause axon 
retraction (Horn et al., 2008). Disruption of the blood brain barrier (BBB) and release of 
cytokines as part of the inflammatory response likely play roles in activating these 




1.5.3 Spinal cord regeneration in newts 
Unlike mammals, adult newts have the remarkable ability to regenerate their 
spinal cords. Their spinal cords regenerate with the regenerating tail after tail amputation 
(Singer et al., 1979), as well as after a gap-inducing SCI such as a complete transection 
(Piatt, 1955). For brevity, the term SCI will be used to refer to a gap-inducing SCI. 
After a complete transection injury to the lower trunk region that paralyzes the 
hindlimbs, newts can regenerate their spinal cords and regain the use of their hindlimbs in 
as little as 4 weeks (Davis et al., 1990). When long-distance projection neurons in the 
brain are retrogradedly labeled 60 days after the injury, about 40% regenerate an axon 
across the lesion and to the hindlimb region compared to uninjured controls, and all brain 
regions that normally project to the hindlimb region regenerate axons across the lesion 
(Davis et al., 1989). Furthermore, the degree of functional recovery is correlated with the 
number of long projection axons that regenerate across the lesion, and recovery is 
abolished when these regenerated axons are once again severed (Davis et al., 1990). This 
implies that recovery requires long distance axons to regenerate across the lesion and re-
establish functional connections with downstream targets. It is not simply due to a 
reorganization of circuits within the spinal cord. Thus, in the newt, all six criteria for 
functional spinal cord regeneration listed above are met. It should also be noted that 
functional recovery does not require neurogenesis. Davis et al (1990) found no evidence 
that new neurons are generated in the brain, and the grey matter at the injury site is not 
restored to its original volume at the time of recovery. While this indicates that 
regeneration of the adult newt spinal cord after SCI may not be perfect, there is evidence 
that, over time, the grey matter is at least partially reconstituted (Butler and Ward, 1967). 
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These findings led us to ask the questions: How do newt axons regenerate through 
and beyond the injury site? Do they have to be guided to and re-establish functional 
synapses with the same targets or can other targets be sufficient? Do the denervated 
targets rewire themselves such that functional recovery is re-established via a new type of 
circuit that includes propriospinal neurons? Answers to these questions will undoubtedly 
help us learn more about what may be necessary for functional recovery in mammals and 
how this may be achieved. Given that the first hurdle we must overcome in mammals 
relates to the second question, I focused on studying how newt axons regenerate through 
and beyond an injury site. 
Axon regeneration may be enabled in the newt by axon intrinsic and/or axon 
extrinsic factors. Newt CNS neurons may be able to activate a high intrinsic growth 
potential, and/or the environment of the injured newt spinal cord may not be inhibitory 
for axon regeneration.  
Much of the research on spinal cord regeneration in newts (and axolotls) has 
focused on spinal cord regeneration after tail amputation, because the surgical procedures 
are easier to perform. Additionally, because EG lining the central canal of the spinal cord 
have properties of neural progenitor cells, much research has focused on the EG response 
and on their potential to produce various cell types after injury. After tail amputation, a 
blastema forms and all of the tissues in the tail regenerate via epimorphosis, except the 
long distance axons that project from the brain. EG upregulate stem cell markers (Walder 
et al., 2003) and are thought to produce new neurons. Unlike regeneration after an SCI in 
newt, the grey matter is fully restored (Nordlander and Singer, 1978). There is even 
evidence that EG progeny contribute to the regeneration of structures outside of the 
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spinal cord, such as the spinal ganglia (Benraiss et al., 1999), muscle, and cartilage 
(Echeverri and Tanaka, 2002). EG also appear to play an important role in enabling axon 
regeneration following tail amputation. They elongate an ependymal tube that precedes 
and serves as a scaffold for regrowing axons (Nordlander and Singer, 1978). In distal 
portions of the regenerating tail, the channels formed by EG radial processes are devoid 
of axons. In more proximal regions, however, the channels contain more axons. The 
ECM associated with regenerating tail tissues, including the spinal cord, contains 
tenascin-C (TN-C), a protein that is sometimes permissive and sometimes inhibitory for 
axon growth, and there is mRNA in situ hybridization evidence that EG express this 
protein in their processes (Caubit et al., 1994). Overall, regeneration after tail amputation 
is thought to proceed as a recapitulation of developmental processes. Singer et al. (1979) 
compared spinal cord formation during development and spinal cord regeneration after 
tail amputation and found that the two processes appeared to be similar. In the context of 
tail regeneration, long distance projection axons grow into newly developing tissues. 
Surprisingly, little is known about how axons regenerate after an SCI in the newt. 
In this context, axons must re-grow through an injury site having mature tissues on both 
sides of the lesion. This context is also more relevant to the problem of spinal cord injury 
in humans. Older studies of SCI in the newt have noted that a blastema and glial scar do 
not appear to form (Piatt, 1955), that axons can bridge large gaps in the cord before 
ependymal tubes elongate (Butler and Ward, 1967; Stensaas, 1983), and that, if left 
intact, the meninges can serve as a scaffold for axon regeneration (Stensaas, 1983). Thus, 
unlike regeneration after tail amputation, a pre-formed ependymal tube is not required for 
axon regrowth after an SCI in the trunk region of the animal (rostral to the hindlimbs). A 
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more recent study analyzed the EG response after an SCI to the tail region of the axolotl 
spinal cord (caudal to the hindlimbs) and found that EG appear to undergo an epithelial to 
mesenchymal transition, migrate into the injury site to form a solid mass of cells, and 
then undergo a mesenchymal to epithelial transition to re-form an ependymal tube that 
serves as a scaffold for axon regeneration (O'Hara et al., 1992; Chernoff et al., 2003). The 
mesenchymal “EG” in the injury site expressed the permissive ECM protein, FN. Though 
the conclusions of this study have dominated the literature as the model of regeneration 
after an SCI in salamanders, other interpretations of the data are possible. For example, 
cells in the injury site that Chernoff and colleagues call EG could, instead, be meningeal 
cells. Furthermore, processes occurring after an SCI to the caudal axolotl spinal cord may 
differ from those occurring after an SCI in the newt or following an SCI to the trunk 
region of the spinal cord.  
In summary, previous studies of spinal cord regeneration in salamanders suggest 
that axon extrinsic factors enable axon regeneration. Physical barriers do not appear to 
form, EG and the meninges may help axons regenerate, and the ECM may contain 
permissive proteins. It is difficult to discern from these studies, however, a clear 
understanding of what happens after an SCI to the trunk region of the spinal cord in the 
newt. Some studies have used newts, others have used axolotls. Some have analyzed 
regeneration after tail amputation, while others have analyzed regeneration after an SCI. 
The SCI is usually in the trunk region but can be in the tail region, and the SCI is usually 
a simple transection but can also be a large ablation. Additionally, in the early studies of 
regeneration after SCI, many of the techniques used were less powerful than those 
available today, the quality of the images were less than optimal by today’s standards, the 
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relationship of the images to the injury/amputation site or regenerating axons is not given, 
and the data presented fail to provide a comprehensive picture of the regenerative 
process. 
To gain a clearer understanding of how axons regenerate through and beyond an 
SCI in the newt, I performed a comprehensive analysis of axon regeneration and the 
cellular and extracellular environment axons encounter within the lesion after an SCI. I 
chose to study regeneration after a complete transection injury to the trunk region of the 
cord so that my study could complement those done by Piatt (1955) and Davis et al 
(1989; 1990). The results are discussed in Chapter 4. To ensure that the images presented 
were of the highest quality, I adapted modern labeling and imaging techniques for use in 
the newt. These techniques are discussed in Chapters 3 and 4. 
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A NOVEL MITOGENIC CXC CHEMOKINE IS INDUCED 
DURING NEWT LIMB REGENERATION 
2.1 Abstract 
Chemokines are cytokines that can induce chemotaxis and proliferation in target 
cell types and have been implicated in many biological processes such as wound healing, 
inflammation, cancer metastasis, stem cell recruitment, and angiogenesis. Here we show 
that a novel newt CXC chemokine (NvCXCL) is markedly upregulated during newt 
forelimb and hindlimb regeneration and that its expression levels peak at days 6-12 
postamputation. NvCXCL is expressed in dedifferentiating tissues in 6-day regenerates 
and in the apical epithelial cap and blastema in 12-day regenerates. NvCXCL can act as a 
mitogen for mouse C2C12 and NIH-3T3 cells and, unlike the well-known mitogen IGF1, 
it can do so even in the absence of stimulating co-factors present in serum. Although we 
found no evidence that NvCXCL was chemotactic for any cell tested, it did appear to 
induce a chemokinetic response in NIH-3T3 fibroblasts. These results suggest that 
NvCXCL may be involved in the formation and growth of the limb blastema by 
promoting cell proliferation.
2.2 Introduction 
Newts and other urodeles have the remarkable ability to regenerate lost 
appendages and injured organs, including limbs, tails, jaws, spinal cords, lenses, optic 
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nerves, heart ventricles, intestines, and parts of the brain (Piatt, 1955; O'Steen, 1958; 
Oberpriller and Oberpriller, 1974; Turner and Singer, 1974b, a; Brockes and Kumar, 
2002). This regenerative ability is dependent upon an unusual degree of cellular plasticity 
at the site of injury. For example, during limb regeneration, differentiated cells just 
proximal to the amputation site lose their differentiated characteristics, re-enter the cell 
cycle, and migrate to the distal end of the stump to form a pool of proliferating progenitor 
cells known as the regeneration blastema (Thornton, 1938a, b; Bodemer and Everett, 
1959; Hay and Fischman, 1961; Steen, 1968; Namenwirth, 1974; Lo et al., 1993; Kumar 
et al., 2000). Resident stem cells that express pax7 and resemble mammalian muscle 
satellite cells also migrate distally to participate in the formation of the blastema 
(Morrison et al., 2006). Once formed, the early blastema grows primarily through the 
proliferation of its progenitor cells until it reaches its maximum size around 21-25 days 
postamputation (dpa). At this time, chondrogenic condensations, which will eventually 
become the bones of the new limb, begin to form in the central region of the regenerate. 
Over about a 7-week period, the regenerate continues to grow and is patterned into the 
new limb as the blastemal cells differentiate into the various tissues that constitute the 
limb. 
Although much has been learned about the cellular responses triggered by limb 
loss, very little is known about the genes that control blastema formation. In zebrafish, 
fgf20 has been shown to be required for blastema formation during fin regeneration 
(Whitehead et al., 2005) but so far, this growth factor has not been implicated in urodele 
limb regeneration. However, other fibroblast growth factors (FGFs) are expressed during 
limb regeneration and beads soaked in FGFs can induce partial limb regeneration 
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following denervation (Mullen et al., 1996). Matrix metalloproteinases (MMPs) are 
required for successful regeneration in several species and tissues, including newt limbs 
(Leontovich et al., 2000; Quinones et al., 2002; Gourevitch et al., 2003; Bai et al., 2005; 
Vinarsky et al., 2005). MMPs may be functioning to prevent scar formation during newt 
limb regeneration (Vinarsky et al., 2005). However, it is not yet known whether MMPs 
play additional roles in the regenerative process that could aid in blastema formation. The 
homeobox gene Msx1 has been implicated in several regenerative processes and may be 
involved in cellular dedifferentiation or the maintenance of the undifferentiated state in 
the blastema (Song et al., 1992; Reginelli et al., 1995; Simon et al., 1995; Odelberg et al., 
2000; Hu et al., 2001; Beck et al., 2003; Han et al., 2003). The anterior gradient gene can 
replace the function of nerves in limb regeneration and rescue regeneration following 
denervation (Kumar et al., 2007). Wnts have also been shown to play a role in 
regeneration in Xenopus and zebrafish (Kawakami et al., 2006; Stoick-Cooper et al., 
2007).    
In an effort to identify additional factors that might be involved in blastema 
formation and growth, we have performed differential expression analyses between 
regenerating (1 to 21 dpa) and intact limbs in the newt species Notophthalmus 
viridescens. These screens have produced several candidate genes. One of these genes is 
a CXC chemokine that is similar yet distinct from mammalian CXCL9, CXCL10, and 
CXCL11. 
CXC chemokines are small, secreted, chemotactic cytokines that are marked by 
four conserved cysteines of which the first two cysteines are separated by only one 
residue (Mortier et al., 2008). CXC chemokines are known to participate in several 
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biological processes including wound healing, inflammation, tumor metastases, cell 
migration, cell proliferation, angiogenesis, and axon guidance (Driscoll et al., 1995; 
Wang et al., 1996; Colletti et al., 1998; Vicari and Caux, 2002; Barbero et al., 2003; Ren 
et al., 2003; Li et al., 2005). CXCL9, 10 and 11 are three chemokines that bind to and 
activate the CXCR3 receptor, are regulated by interferon-γ, and have been shown to 
induce chemotaxis and proliferation in lymphocytes (Muller et al., 2010).  
Given that blastema formation and growth requires both cell migration and 
proliferation, we decided to characterize this CXC chemokine, which we tentatively call 
NvCXCL. We found that NvCXCL is highly upregulated during newt limb regeneration 
and reaches maximum expression levels at 6 and 12 dpa in the regenerating newt 
hindlimb and forelimb, respectively. We show that it is expressed in dedifferentiating 
tissues, the regeneration blastema, and the AEC. Finally, we demonstrate that purified 
recombinant NvCXCL can act as a mitogen for both mouse myoblast and fibroblast cell 
lines and as a chemokinetic agent for the mouse fibroblast cell line. These data suggest 
that NvCXCL may play an important role in the formation and/or growth of the 
regeneration blastema. 
2.3 Results 
2.3.1 Cloning of the NvCXCL gene 
We originally identified NvCXCL by differential display as a gene that was 
upregulated during the dedifferentiation stage of newt forelimb regeneration (1, 3 and 5 
dpa). We used the 365 bp differential display product to generate a full-length cDNA 
clone of 737 bp using RNA Ligase Mediated-Rapid Amplification of cDNA Ends (RLM-
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RACE) (Vinarsky et al., 2005; Stevenson et al., 2006). This clone was sequenced and an 
open reading frame of 324 nucleotides was identified having a predicted amino acid 
sequence that placed it in the family of CXC chemokines (Figure 2.1). Although we 
could not identify a true ortholog of the NvCXCL gene, we were able to show that it was 
most similar to the three mammalian interferon-γ inducible CXC chemokines CXCL9, 
CXCL10, and CXCL11, with amino acid identities varying between 27 and 34% and 
similarities between 45 and 57%. 
2.3.2 NvCXCL is upregulated in regenerating newt limbs 
during blastema formation and growth 
Microarray, real-time RT-PCR, and Northern blot analyses confirmed that 
NvCXCL was upregulated in both proximal (mid-stylopodial amputations) and distal 
(distal zeugopodial amputations) forelimbs during the period of dedifferentiation and 
blastema formation (Figure 2.2 and data not shown), suggesting that this chemokine 
might be involved in blastema formation and growth. Peak expression levels in the newt 
forelimb were reached at 12 dpa, with real-time RT-PCR revealing a 6.5-fold 
upregulation in the proximal limb and a 43.2-fold upregulation in the distal limb. Given 
this marked upregulation in the newt forelimb, we also examined expression levels in the 
newt hindlimb and found that a maximum 36.3-fold upregulation was reached by 6 dpa in 
the proximal hindlimb. Figure 2.2 also demonstrates that NvCXCL is markedly 
downregulated in the newt forelimb early in the regeneration process through at least day 
6. However, this downregulation is not seen in the regenerating hindlimb and its 








Figure 2.1. Predicted amino acid sequence of NvCXCL and a comparison 
to other CXC chemokines. A: NvCXCL is a 107 amino acid (aa) protein 
that contains the four conserved cysteine residues (asterisks) indicative of 
CXC chemokines and a cleaved 21 aa signal peptide. Based on sequence 
homologies, it appears to be a novel CXCL similar to other interferon-
γ inducible CXC chemokines but with no clear ortholog. Mammalian 
CXCL sequences were obtained from GenBank:  Cow CXCL11, CXCL9, 
and CXCL10 (Accession numbers NM_001113173, NM001113172, and 
NM_001046551, respectively); Wild boar CXCL11, CXCL9, and 
CXCL10 (Accession numbers NM_001128491, NM_001114289, and 
NM_001008691, respectively); Human CXCL11, CXCL9, and CXCL10 
(Accession numbers NM_005409, NM_002416, and NM_001565, 
respectively). B: A Phylip’s tree phylogram based on ClustalW2 analysis 
showing that NvCXCL is most closely, though distantly, related to the 
interferon-γ-inducible CXC chemokines. Hs, human; Bt, cow; Ss, wild 
boar; Rn, rat; Mm, mouse; Cf, dog; Ec, horse; Oa, sheep; Ip, catfish; Dr, 












Figure 2.2. Dynamic expression of NvCXCL during newt limb 
regeneration. A: Microarray analysis reveals that NvCXCL expression is 
downregulated in the newt forelimb over the first 6 days of regeneration, 
then rapidly upregulated by day 12 dpa, and drops by 21 dpa. During 
hindlimb regeneration, NvCXCL appears to be upregulated by 3 dpa, 
reaches peak expression levels by 6 dpa, and then slowly declines in 
expression through 21 dpa. B:  Real-time RT-PCR confirms the 
microarray expression data. y-axis is in log10 scale. The numbers above the 
bars indicate the fold-change in linear scale. stylopod = proximal limb; 
zeugopod = distal limb. 
 31 
 32 
variety of experimental techniques including microarray and Northern blot analyses (data 
not shown) have revealed a variable expression pattern in regards to the timing and level 
of NvCXCL up- or downregulation following limb amputation. However, in all studies, 
NvCXCL was consistently observed to be upregulated during the late 
dedifferentiation/early blastema stage at 12 dpa. 
2.3.3 NvCXCL is expressed in dedifferentiating  
tissues and in the blastema and AEC 
RNA in situ hybridization at days 6 (hindlimb stylopod) and 12 (forelimb 
zeugopod) using three different newts for each analysis confirmed that NvCXCL is 
consistently upregulated at these time points and also revealed the spatial expression 
patterns of this chemokine (Figure 2.3). At 6 dpa, the hindlimb stylopod expresses 
NvCXCL in the dedifferentiating muscle tissues, while at 12 dpa, NvCXCL is expressed in 
the nascent blastema, AEC, and dedifferentiating muscle tissues of the regenerating 
forelimb zeugopod. These expression data are consistent with a possible role for NvCXCL 
in limb regeneration during the periods of dedifferentiation/blastema formation and 
blastemal growth. 
2.3.4 Purification of recombinant NvCXCL protein 
Using affinity chromatography, we purified a recombinant NvCXCL protein 
possessing a FLAG-tag on its C-terminal end from the conditioned medium of transfected 
HEK293 cells. Western blot analysis revealed a protein with an apparent molecular 
weight of ~13 kDa (Figure 2.4). Given that the predicted weight of secreted NvCXCL, 









Figure 2.3. Spatial expression patterns of NvCXCL mRNA during newt 
limb regeneration. Longitudinal sections were imaged on a confocal 
microscope and 2-3 confocal planes were z-projected into one image to 
represent signal from the full thickness of the section. NvCXCL mRNA is 
shown in red and nuclei are shown in green. A: NvCXCL is expressed at 
very low levels in at 0 dpa (intact limb). B: At 6 dpa (dedifferentiation 
stage), the proximal hindlimb (stylopod) expresses NvCXCL in the 
dedifferentiating mesodermal tissues (especially the muscle) of the limb 
stump. C: At 12 dpa (early blastemal stage), the distal forelimb 
(zeugopod) expresses high levels of NvCXCL in the blastema, apical 
epithelial cap, and dedifferentiating muscle of the limb stump. D: A 12 
dpa, the distal forelimb hybridized with a sense NvCXCL probe to 
confirm specificity of the signal. e = epithelium; m = muscle; b = bone; bl 















Figure 2.4. Western blot of affinity chromatography purified NvCXCL. 
Secreted FLAG tagged-NvCXCL migrates as a 13 kDa protein during 
reducing SDS-polyacrylamide gel electrophoresis. 
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is either co- or posttranslationally modified. N-linked glycosylation is unlikely given that 
no cognate N-X-S/T motifs (where X is any amino acid except proline) are found in 
NvCXCL (see Figure 2.1). However, there is one theoretical O-linked glycosylation site 
at S79. It remains to be determined whether this site is glycosylated or some other protein 
modification is responsible for the apparent upward shift in the molecular weight of 
NvCXCL. 
2.3.5 NvCXCL can act as mitogen on mouse  
myoblast and fibroblast cell lines 
Several recent studies have shown that CXC chemokines can act as mitogens on 
certain cell types (Bajetto et al., 2001; Barbero et al., 2002; Murphy et al., 2005; Porcile 
et al., 2005; Bajetto et al., 2006; Barbieri et al., 2006). To determine whether NvCXCL 
can function as a mitogen on cell types known to contribute to blastema formation, such 
as myoblasts and fibroblasts, we used the WST-8 assay to assess cell proliferation in 
vitro. We found that NvCXCL acts as a potent mitogen on mouse C2C12 myoblasts and 
mouse NIH/3T3 fibroblasts (Figure 2.5). In this assay, subconfluent cell cultures were 
deprived of serum for 24 hours to arrest and synchronize the cell cycle. The cells were 
then stimulated with various concentrations of either NvCXCL or IGF1 (positive 
mitogenic control) for 2 days and then treated with WST-8 for 2 hours at 37°C. Viable 
cells cleave the WST-8 reagent to produce a chromogenic substance that can be detected 
and quantified by measuring absorbance at 450 nm. The absorbance is directly 
proportional to the number of viable cells and can be used to assess relative cell number 










Figure 2.5. NvCXCL acts as a mitogen on mouse myoblast and fibroblast 
cell lines. A-B: NvCXCL acts as a mitogen on mouse C2C12 myoblasts in 
a dose-dependent manner both in the presence of low serum 
concentrations (A) and in the absence of serum co-factors (B). C-D: 
NvCXCL acts as a mitogen on mouse NIH/3T3 fibroblasts in a dose 
dependent manner in the presence of low serum concentrations (C) and in 
the absence of serum cofactors (D). IGF = IGF1 (mitogen positive 
control). Results for NvCXCL were compared to the no protein control 
using one-way ANOVA and Tukey-Kramer post hoc test, while results for 
IGF were compared to the no protein control using Student’s t-test. * p < 





dose-dependent proliferative response following stimulation of mouse C2C12 myoblasts 
and NIH/3T3 fibroblasts with NvCXCL both in the absence of serum and in the presence 
of low serum concentrations. At 40-80 ng/ml NvCXCL, both cell types exhibited a robust 
response, while at 10 ng/ml, C2C12 cells proliferated when cultured in the presence of 
0.5% horse serum. The magnitude of the proliferative response was similar to that 
observed when the cells were exposed to the mitogen IGF1 (100 ng/ml) in the presence 
of low serum concentrations indicating that NvCXCL is a potent mitogen for these 
mammalian cell types. However, unlike IGF1, which requires a serum cofactor for 
mitogenic activity (Napier et al., 1999), NvCXCL acted as mitogen even in the absence 
of serum cofactors. 
Chemokines are also known to be chemotactic factors. To test whether NvCXCL 
might also be chemotactic, we used a Neuro Probe chemotaxis assay to determine 
whether NvCXCL could promote the directed migration of NIH/3T3 fibroblasts (Figure 
2.6). Although we observed a statistically significant 2.5-fold increase in cell migration 
upon stimulation of NIH/3T3 cells with 80 ng/ml NvCXCL, the chemokinetic control 
suggested that the limited migratory effect was not due to chemotaxis but rather to a 
general stimulation cell motility (Figure 2.6). Furthermore, the observed 2.5-fold increase 
in cell migration was small when compared to the 9-fold increase in cell migration we 
observed upon stimulation of NIH/3T3 cells with 1 nM (~30 ng/ml) of human 
recombinant PDGF-BB (positive chemotactic control). These results suggest that 
NvCXCL does not act as a chemotactic agent for NIH/3T3 cells, although we do not yet 











Figure 2.6. NvCXCL acts as chemokinetic but not chemotactic factor on a 
mouse fibroblast cell line. NvCXCL induced chemokinesis (random 
nondirectional migration) of mouse NIH/3T3 fibroblasts at the highest 
concentration tested (80 ng/ml), but did not induce chemotaxis (directional 
migration), given that there was no statistically significant difference in 
cell migration between the chemokinetic control and the test for 
chemotaxis. PDGF-BB was used as a positive control for chemotaxis. 
Results were analyzed using one-way ANOVA and Tukey-Kramer post 






During newt limb regeneration, a blastema consisting of proliferating progenitor 
cells is formed at the distal tip of the limb stump. Although the blastemal cells are 
thought to be derived from the combined effects of tissue dedifferentiation and activation 
of resident stem cells (Lo et al., 1993; Kumar et al., 2000; Morrison et al., 2006), the 
mitogenic factors that drive the proliferative response have not yet been identified. Here, 
we identify a mitogenic CXC chemokine, NvCXCL, which is expressed in the 
regenerating limb during the dedifferentiation and blastemal stages and could therefore 
play a role in the proliferative response. NvCXCL is expressed in the AEC, in muscle 
tissue that is undergoing tissue dedifferentiation, and in the early blastema. This spatial 
expression pattern suggests that this chemokine may function in blastema formation and 
growth. We have shown that NvCXCL can function as a potent mitogen for C2C12 
myoblasts and NIH/3T3 fibroblasts.   
Newt myoblasts and fibroblasts are thought to play a major role in blastema 
formation (Muneoka et al., 1986; Morrison et al., 2006), so observing these proliferative 
effects on mammalian myoblasts and fibroblasts suggests that NvCXCL might be playing 
a role in establishing the regeneration blastema by inducing the proliferation of cells that 
will contribute to the blastema. We tested this hypothesis by treating the newt A1 cell line 
(limb myoblasts) (Ferretti and Brockes, 1988) and a blastemal cell line with NvCXCL in 
vitro. We were unable, however, to observe any signs of a proliferative response (data not 
shown). These negative results could indicate that newt limb myoblasts and blastemal 
cells are not induced by NvCXCL to proliferate in vivo. It is also possible, however, that 
prolonged culture of these cell lines has altered them so they are no longer able to 
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respond to this potent mitogen. Additionally, blastemal cell types competent to respond to 
NvCXCL may not be represented in the blastemal cell line used in this study. Blastemal 
cells are likely a mixture of different types of progenitor cells, including progenitors for 
muscle, cartilage, bone, and connective tissue. Once cultured and subjected to multiple 
passages, certain cell types would be expected to predominate, while others would be lost 
due to differential proliferation. Therefore, newt cell types that might be responsive to the 
mitogenic effects of NvCXCL could be absent from the pool of surviving blastemal cells. 
It would be interesting to determine whether Pax7+ primary myoblasts derived from newt 
muscles express the NvCXCL receptor and are responsive to the mitogen. This intriguing 
possibility awaits testing.   
Though chemokines are known to have potent chemotactic properties, we were 
unable to confirm that NvCXCL is chemotactic for the mammalian or newt cell lines 
tested. This may indicate, again, that potentially responsive cell types were not tested. 
Chemokines are known to be especially chemotactic for immune cells. CC chemokines 
often induce chemotaxis of monocytes, eosinophils, basophils, B and T lymphocytes, 
natural killer cells, or dendritic cells, while CXC chemokines induce chemotaxis of 
neutrophils, monocytes, T cells, and B cells with the interferon-γ inducible CXC 
chemokines (CXCL9, CXCL 10, and CXCL11) acting as potent activators of T cell and 
monocyte migration (Proost et al., 2001). We did not test whether NvCXCL could induce 
chemotaxis of immune cells, primarily because its expression levels do not peak until 6-
12 dpa, which is well after the inflammatory reaction has been initiated (Mescher and 
Neff, 2006). It is also possible that we were unable to detect NvCXCL’s chemotactic 
properties because they were lost as a result of post-translational modifications. It is 
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known that such modifications, especially peptidase cleavages, can alter a chemokine’s 
ability to act as a chemotactic agent. For example, cleavage of the N-terminal amino 
acids of CXCL9, CXCL10, and CXCL11 decreases the chemotactic activity of these 
chemokines and can even cause them to become chemotactic antagonists, while still 
retaining their other normal biological functions (Proost et al., 2006). Although our 
Western blot data indicate that post-translational modifications of NvCXCL increase the 
apparent molecular weight of the protein, we cannot rule out the possibility that 
concurrent modifications, such as minimal N-terminal cleavage coupled with 
glycosylation, could produce a larger than expected protein that has lost its chemotactic 
properties. In this regard, it is interesting to note that the NvCXCL protein does not have 
an N-terminal penultimate proline following removal of the signal peptide (amino acid 23 
of the full-length protein shown in Figure 2.1). Instead, the newt protein has a 
phenylalanine at this position. A proline at the penultimate position is thought to confer 
protection from aminopeptidase cleavage (Proost et al., 2006). Most interferon-γ 
inducible chemokines possess this protective proline (see Figure 2.1). Therefore, 
NvCXCL may be more susceptible to N-terminal degradation and therefore loss of any 
chemotactic properties it might have originally possessed.  
Further analyses will be required to determine the precise role of NvCXCL in the 
regenerative process. An intriguing possibility may be that different types of blastemal 
cells require different mitogens for their propagation. NvCXCL might be an important 
mitogen for fibroblasts and Pax7+ myoblasts, while other mitogens could be required to 
induce proliferation of other blastemal cell types. Furthermore, it has recently been 
shown that the transitional matrix of the early limb regenerate contains ECM molecules 
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such as tenascin-C and fibronectin that can enhance cell proliferation (Calve et al., 2010). 
How these ECM molecules interact with other growth factors and mitogens, such as 
NvCXCL, to establish the blastema is not yet known. As additional regeneration-
associated mitogens are identified, it will be important to determine the interactive roles 
these mitogens and ECM molecules play in establishing a pool of programmed progenitor 
cells capable of replacing a lost limb. 
2.5 Experimental procedures 
2.5.1 Newt limb amputations 
All procedures involving newts were approved by the University of Utah 
Institutional Animal Care and Use Committee. Anesthesia was accomplished by 
immersing the newts in 0.1% ethyl 3-aminobenzoate methanesulfonic acid and limb 
amputations were performed as previously described (McGann et al., 2001; Vinarsky et 
al., 2005). At the designated time points, regenerating limbs were reamputated 
approximately 1.5 mm proximal to the limb stump. 
2.5.2 Differential display 
Differential display was performed according to manufacturer’s instructions 
(GenHunter) as previously described using RNA isolated from intact forelimbs and 
forelimbs at 1, 3, and 5 dpa (Vinarsky et al., 2005). 
2.5.3 RNA ligase-mediated-RACE and  
cloning full-length NvCXCL 
RNA Ligase-Mediated-RACE (RLM-RACE) was performed as previously 
described (Vinarsky et al., 2005; Stevenson et al., 2006) using nested 3’-primers specific 
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to NvCXCL and nested 5’-primers specific to the RNA linker that had been ligated to the 
5’-end of the NvCXCL transcript.  RLM-RACE products were TA-cloned into 
pBluescript II and sequenced. 
2.5.4 Microarray analysis 
Custom microarrays were prepared by Agilent Technologies using both in-house 
DNA sequence data and data from public databases. Each microarray represented 1,876 
putative transcripts from 6 newt species with 93% of the transcript sequences being 
derived from Notophthalmus viridescens. The majority of the N. viridescens genes were 
cloned from mRNA isolated from regenerating tissues; therefore this microarray is 
enriched for genes that are expressed during regeneration. A 60-mer probe was designed 
for each transcript using Agilent eArray software, and each probe was represented 23 
times on a grid containing 44,000 oligonucleotide probes. Newt limbs were amputated 
through the stylopod or zeugopod of the forelimb and hindlimb and RNA was isolated 
from regenerating tissues collected at 0 (intact), 1, 3, 6, 12, or 21 days. The Huntsman 
Cancer Institute Microarray Core Facility at the University of Utah prepared the RNA 
probes and performed the hybridizations. RNA probes were generated by amplifying the 
isolated RNA and labeling with Cy3 or Cy5. Microarrays were competitively hybridized 
with Cy3- and Cy5-labeled probes from regenerating and day 0 (intact) tissues. 
Following hybridization, the quality reports for each microarray were examined to ensure 
uniformity of median signal intensities, to determine the number of bad features on each 
array, and to confirm that radiometric controls were performing as expected. All bad 
features were eliminated from further analysis (bad features typically represented < 0.1% 
of all spots on the array). The microarrays were Lowess normalized, the Cy5:Cy3 ratio 
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(regenerating vs. intact tissues) for each hybridization was log10 transformed, and 
geometric means and standard deviations were obtained for repetitive hybridizations. 
2.5.5 Real-time RT-PCR 
Real-time RT-PCR was performed as previously described (Atkinson et al., 2006; 
Stevenson et al., 2006) using the Bio-Rad iScript cDNA Synthesis Kit, a mixture of poly-
dT and random primers, iTaq SYBR Green Supermix with ROX (Bio-Rad), and the ABI 
Prism 7700 Sequence Detection System. Data were analyzed using the standard curve 
method and normalized to the control gene Nvg00818. Nvg00818 is a newt gene 
expressed in regenerating limbs that exhibits no differential expression over regeneration 
time as assessed by microarray analysis. No homology to any other cloned gene has yet 
been identified. Specific primers for NvCXCL and the control gene were designed using 
the Beacon Designer 3.01 program (Premier Biosoft International): 1) NvCXCL fwd 
(175cf1) 5’-ACTGCTTAGAAACCCTGAG-3’; 2) NvCXCL rev (175cr1), 5’-
GTGGACGGATTTGACTAAAG-3’; Nvg00818 fwd (4n02a-2f) 5’-
GCAGTTGACTGCAGATATTCAA -3’; and Nvg00818 rev (4n02a-1r) 5’-
TCGGCGTAAGATGTTTATTGTAA-3’.  
2.5.6 In situ hybridization 
All steps were performed at room temperature (RT) unless otherwise specified. 
Intact and 6-day regenerating proximal hindlimbs (stylopod) and intact and 12-day 
regenerating distal forelimbs (zeugopod) were harvested from anesthetized animals, fixed 
with 4% paraformaldehyde (PFA) in PBS overnight at 4°C, and rinsed with PBS. Limbs 
were decalcified with Morse’s solution (22.5% formic acid, 10% sodium citrate) for 24 
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hrs, rinsed with PBS, dehydrated in a series of solutions containing increasing 
concentrations of ethanol (50%, 70%, 95%, 100%, 30 min each; 100%, 1 hr), infiltrated 
with paraffin (75% Hemo-De in EtOH, 20 min; 100% Hemo-De, 1 hr; paraffin, 1 hr, 
60°C, 15 Hg vacuum), and embedded in paraffin. Sections 10-12 µm thick were mounted 
onto slides, left on a 37°C slide warmer overnight, and stored at 4°C. Prior to ISH, 
sections were dewaxed (Hemo-De, 10 min, 2 times; 75% Hemo-De in EtOH, 5 min; 
100% EtOH briefly, then 3 min) and rehydrated into PBS (95% EtOH, 3 min; 70% EtOH, 
3 min; PBS, 5 min). Sections were then post-fixed with 4% PFA in PBS for 15 min, 
washed with PBS for 5 min, quenched of endogenous peroxidases with 1% H2O2 in PBS 
for 30 min, washed with PBS for 5 min, and permeabilized with 5 µg/ml Proteinase K in 
TE (100 mM Tris-HCl, 50 mM EDTA, pH 8.0) for 15 min at 37°C. Sections were 
washed with PBS for 5 min, briefly equilibrated in TEA (0.1 M triethanolamine, pH 8.0), 
acetylated with 0.25% acetic anhydride in TEA for 15 min, washed in PBS for 5 min, and 
pre-hybridized in hybridization buffer (4X SSC, 50% formamide, 1X Denhardt’s 
solution, 200 µg/ml yeast RNA, 500 µg/ml heat denatured herring sperm DNA, 10% 
PEG6000) for 30 min at 55°C. Digoxigenin-labeled riboprobes were diluted in 
hybridization buffer to 500 µg/ml, heat denatured for 3 min at 80°C, and added to the 
sections. Sections were hybridized in a humidified box overnight at 55°C. After 
hybridization, sections were briefly washed at 55°C in wash solution (4X SSC, 50% 
formamide, 1X Denhardt’s solution). Subsequent washes included a series of solutions 
with lowering concentrations of wash solution (100% wash solution, 75% wash 
solution/25% 2X SSC, 50% wash solution/ 50% 2X SSC, and 25% wash solution/75% 
2X SSC) for 10 min each, two washes with 2X SSC for 20 min each, two washes with 
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0.2X SSC for 20 min each, and then two washes at RT in MABT (100 mM maleic acid, 
150 mM NaCl, 0.1% Tween-20, pH 7.5) for 10 min. Sections were then blocked with 
MABTB (MABT with 1% BSA and 10% heat inactivated horse serum) for 1hr, incubated 
overnight at 4°C with anti-DIG-POD (HRP) antibody (Roche, 11207733910, 150 U/ml) 
diluted 1:1000 in MABTB, rinsed five times with MABT for 10 min, rinsed with TNT 
(100 mM Tris-HCl, 150 mM NaCl, 0.05% Tween-20, pH 7.5) for 10 min. The signal was 
then amplified by incubating the sections in tyramide-Cy5 (PerkinElmer, NEL745001KT; 
Waltham, MA) diluted 1:50 in diluent for 20 min. Sections were washed 5 times with 
TNT for 10 min, incubated with SYTOX green nucleic acid stain (Invitrogen, S7020; 
Carlsbad, CA) diluted 1:50,000 in 2% in DMSO in TNT for 15 min, washed with TNT, 
then 50% TNT, then water for 5 min each wash. Sections were mounted with 
Fluoromount G (Thermo Fisher Scientific, OB100-01; Rockford, IL) and coverslips were 
sealed with clear nail polish. Sections were imaged on an Olympus FV300 laser scanning 
confocal microscope using a 10X or 20X air objective. Images were processed with 
Image J, version 1.40g (W. Rasband; http://rsb.info.nih.gov/ij; NIH, Bethesda, MD) and 
Adobe Photoshop CS2. Levels were adjusted in Photoshop to maximize the signal to 
noise ratio but the same adjustments were made to experimental and control images. 
2.5.7 Expression and purification of  
recombinant NvCXCL 
cDNA containing the complete open reading frame of NvCXCL and a 3’-FLAG 
sequence (coding for the C-terminal sequence DYKDDDDK) was cloned into the 
pCMV-SPORT6 vector (Invitrogen, Carlsbad, CA). The recombinant clone was 
transfected into human embryonic kidney 293H cells using Lipofectamine 2000 
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(Invitrogen, Carlsbad, CA), 100-200 ml of serum-free conditioned medium was collected 
at 24-96 hours posttransfection, and FLAG-tagged NvCXCL was purified by affinity 
chromatography using the anti-FLAG M2 antibody (Sigma-Aldrich, St. Louis, MO) as 
previously described (Vinarsky et al., 2005). Concentration of the protein was estimated 
by comparison to a FLAG-tagged bovine alkaline phosphatase standard (Sigma-Aldrich, 
St. Louis, MO) following Western blotting and chemiluminescence detection using the 
SuperSignal West Femto reagent (Thermo Fisher Scientific—Pierce, Rockford, IL). 
2.5.8 Proliferation assay 
C2C12 and NIH/3T3 cells (mouse myoblast and fibroblast cell lines, respectively) 
were purchased from the American Type Culture Collection (ATCC, Rockville, MD) and 
grown at 37°C/5% CO2 in DMEM (high glucose, 4.5 g/l) supplemented with 4 mM 
glutamine, 10% FBS, 100 U/ml penicillin, and 100 µg/ml streptomycin. Cells were plated 
in quadruplicate in 100 µl volumes on 96-well tissue culture plates at 5,000 cells/well. 
Cells were allowed to attached overnight, rinsed once with PBS and synchronized for 20-
24 hours with either serum-free medium or medium containing 0.5% horse serum. Cells 
were then treated with synchronization medium alone (negative control) or synchroniza-
tion medium supplemented with either 100 ng/ml insulin growth factor 1A (IGF1A; 
positive control) or varying concentrations of NvCXCL (1, 10, 40, or 80 ng/ml). After 2 
days of treatment, the cells were assayed for cell number using the WST-8 assay 
(Dojindo) as described previously (Stevenson et al., 2006). ANOVA was used to assess 
the differences between the cell number means and a Tukey-Kramer post hoc test was 
used to assess statistical differences between the individual treatment groups. 
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2.5.9 Chemotactic assay 
Chemotactic function was assessed according to manufacturer’s instructions using 
a Neuro Probe chemotactic system (Gaithersburg, MD) and fibronectin-coated 
membranes having 8 µm diameter pores. NIH/3T3 cells were treated with serum-free 
medium overnight to ensure quiescence. The lower chambers of the system were loaded 
with serum-free medium (negative control), 1 nM (~30 ng/ml) PDGF-BB (positive 
control), or varying concentrations of NvCXCL (10 ng/ml, 40 ng/ml, or 80 ng/ml). Upper 
chambers were loaded with 30,000 quiescent NIH/3T3 cells either in the absence 
(chemotactic test) or presence (chemokinetic control) of equimolar concentrations of the 
protein (NvCXCL or PDGF-BB). Each condition was done in quadruplicate. Cell 
migration was allowed to proceed at 37°C/5% CO2 for 4 hours. Membranes were fixed, 
stained with hematoxylin and eosin, and nonmigrated cells from the upper chamber side 
of the membrane were removed with a moist cotton swab before mounting the membrane 
using Permount. For each well, cell counts were obtained and summed for four randomly 
selected regions of the membrane. Mean and standard error of the mean were calculated 
for the quadruplicate samples and ANOVA and Tukey-Kramer posthoc tests were 
performed to assess statistical significance of the results. 
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 CHAPTER 3 
FLUORESCENT WHOLE-MOUNT METHOD FOR VISUALIZING  
THREE-DIMENSIONAL RELATIONSHIPS IN INTACT AND  
REGENERATING ADULT NEWT SPINAL CORDS 
3.1 Abstract 
Adult newts have the remarkable ability to regenerate their spinal cords after a 
complete transection injury. In order to understand this process, we have developed a 
method for visualizing the cellular and molecular events during regeneration in whole-
mount preparations using fluorescent probes (streptavidins and antibodies) and confocal 
microscopy. This method was optimized by varying parameters associated with fixation, 
tissue trimming, fluorescent probe penetration, and clearing and represents a significant 
advance in our ability to observe the intact and regenerating newt spinal cord. These 
methods should also be widely applicable to the study of other newt tissues and adult 
tissues from other model systems.
3.2 Introduction 
Often, the first step in understanding a complex biological process is to carefully 
observe the process, to identify the structural, cellular or molecular players and watch 
their behaviors. Ideally, this is best done in a way that maintains three-dimensional (3D) 
relationships. While 3D relationships can be reconstructed from images of serial sections, 
this method is time consuming and introduces artifacts. Individual sections can be warped 
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or torn, and this can make it difficult to faithfully reconstruct the 3D image. A better and 
more efficient way to observe 3D relationships is to image tissues in whole-mount on a 
confocal microscope. For this method, the tissue must be fluorescently labeled, optically 
clear, and not more than about 300 µm thick. Thus, zebrafish embryos, which are clear 
and small, are ideal for confocal microscopy and can even be imaged live if fluorescent 
labels are introduced in vivo. Many specimens, however, must be trimmed, fluorescently 
labeled ex vivo, and cleared after an animal has been sacrificed and its tissues fixed. 
While methods for performing each of these steps have been established for many 
developmental model organisms (Klymkowsky and Hanken, 1991; Kardon, 1998), these 
methods have not been optimized for use in many adult tissues, which are larger and less  
permeable, or for use in many less common model organisms, such as the newt.  
Newts are remarkable for their ability to regenerate body parts after they are lost 
or damaged. A newt can regenerate its limbs (Brockes, 1997), tail (Iten and Bryant, 
1976), jaw (Ghosh et al., 1994), retina (Mitashov, 1996), lens (Eguchi et al., 1974), 
portions of its heart (Oberpriller and Oberpriller, 1974) and even its spinal cord (Piatt, 
1955). After a complete transection injury to the spinal cord, the newt can regenerate its 
spinal cord and regain the use of its hindlimbs and tail in as little as 4 weeks (Davis et al., 
1990). To begin to understand how newts are able to do this, we sought to develop 
methods that would allow us to visualize with unprecedented clarity the cellular and 
molecular events after a spinal cord transection injury in the adult newt. 
Here we report a method for obtaining 3D images of intact and regenerating 
spinal cords of adult newts via confocal microscopy that was optimized by varying 
parameters associated with fixation, tissue trimming, fluorescent labeling, and clearing. 
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This method will be invaluable for future studies of spinal cord regeneration in the newt, 
as well as for the development of methods for obtaining 3D images of other newt or adult 
tissues.  
3.3 Results and discussion 
The sequential steps to our method are as follows: fixation, bone decalcification 
(to prepare for trimming), bleaching (part of clearing), embedding and vibratome 
sectioning (to trim the tissue), permeabilization and incubation with fluorescent probes, 
and clearing (Table 3.1). Parameters tested for each step were evaluated on 4 mm 
segments of spinal cord from the lower trunk region of the animal. Spinal cords were 
intact or regenerating after a transection injury. In some animals, the axon tracer, 
biotinylated dextran amine (BDA), was applied in vivo and visualized with streptavidin-
Cy5. The method was first optimized for the streptavidin probe because of its smaller size 
(about 60 kDa) and was then later modified to work with antibodies, which are much 
larger (150 kDa for IgG, 900 kDa for IgM). Spinal cords were imaged on a confocal 
microscope through the dorsal-ventral axis, such that each confocal plane is a 
longitudinal section. Table 3.1 shows the parameters that were tried for each step and 
identifies the preferred conditions for streptavidin and antibody labeling.  
3.3.1 Fixation 
We sought a fixative that would preserve cellular morphology and molecular 
antigenicity and still allow fluorescent probes to penetrate fully into the newt spinal cord. 
Fixatives tried included glutaraldehyde (GA), paraformaldehyde (PFA), and periodate 





Table 3.1. Sequential steps, parameters tested for each step and preferred conditions for 
streptavidin and antibody labeling 
Preferred Conditions for: Sequential 
Steps 
Parameters Tested 
Streptavidin Labeling Antibody Labeling 
fixation 
PLP with 0.5% PFA 
PLP with 2% PFA 
2% glutaraldehyde/ 2% PFA 
perfusion vs nonperfusion 
perfuse & post-fix 
PLP with 0.5% PFA 
post-fix without perfusion 
PLP with 0.5% PFA 
decalcification Morse’s solution Morse’s solution Morse’s solution 
bleaching 
modified Dent’s bleach 
formamide bleach 
formamide bleach formamide bleach 
embedding 3%, 4%, and 6% agarose 4% agarose 4% agarose 
sectioning 
100 – 400 um 






20% DMSO with one of: 
0.5 – 2% Triton X-100 (non-ionic) 
1% Tween-20 (weaker non-ionic) 
1% NP-40 (stronger non-ionic) 
1% CHAPS (zwitterionic) 
1% SDS in pretreatment (ionic) 
20% DMSO 
0.5% Triton X-100 
20% DMSO 
2% Triton X-100 
incubation 
1 – 10 days 
96 well plate 
small centrifuge tubes 
7 days 
96 well plate or  
centrifuge tubes 
10 days 1° 








it preserves morphology very well, but because it interacts strongly with proteins, it tends 
to disrupt antigen-antibody interactions. PFA does not preserve morphology as well as 
GA, but it is more commonly used for immunohistochemistry because it does not cross-
link proteins and disrupt antigenicity as much as GA. PFA, however, tends to add 
autofluorescence to the already highly autofluorescent newt tissues. Finally, PLP was 
tried because it was found to preserve morphology as well as GA (McLean and Nakane, 
1974), and because it can be effective with lower concentrations of PFA, it may reduce 
autofluorescence and allow fluorescent probes to more readily enter the tissue, while still 
preserving antigenicity. Alcohol-based fixatives were not tried because they tend to 
denature antigens, and molecules that are soluble in alcohol are lost. (McLean and 
Nakane, 1974; Klymkowsky and Hanken, 1991; Rogers, 1999).  
The fixatives were evaluated in newt spinal cords that had regenerated 3 days 
after a spinal cord transection (Figure 3.1). BDA was applied rostral or caudal to the 
injury site to label descending or ascending axons, respectively. Animals were perfused 
with 2% GA/2% PFA, PLP with 2% PFA or PLP with 0.5% PFA, and 4 mm of spinal 
column containing the injury site was postfixed in PLP with 2% PFA (after GA/PFA and 
PLP with 2% PFA perfusion) or PLP with 0.5% PFA (after PLP with 0.5% PFA 
perfusion). One animal was not perfused, but was only postfixed with PLP with 2% PFA. 
All tissues were trimmed to a thickness of 400 µm, except the nonperfused tissue which 
was trimmed to 300 µm, and incubated with streptavidin-Cy5 for 4.5 days. 
As shown in Figure 3.1, morphology was well preserved and the amount 
of autofluorescence was low in all animals, regardless of which fixative was used 











Figure 3.1. Comparison of different methods of fixation. A-E: Dorsal 
views of 3 day regenerating spinal cords, fixed as indicated above each 
panel, imaged on a confocal microscope and 3D-rendered in Fluorender. 
The axon tracer, BDA, was applied rostral (C) or caudal (A,B,D,E) to the 
injury site (asterisk in B), labeled with streptavidin-Cy5 for the duration 
indicated above each panel, and is shown in white. Arrowheads in B mark 
the end of the cut spinal cord. A’-E’: Cross sectional views of the same 
cords shown in A-E. R, rostral; C, caudal; D, dorsal; V, ventral. Scale 
bars: 100 µm.  
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fixatives did have an effect, however, on how far the streptavidin probe was able 
to penetrate into the spinal cord. This is evident when the spinal cords are viewed 
in cross section (Figure 3.1A’-D’). Though not complete after 4.5 days of 
incubation, penetrance was best when the fixative with the least amount of 
formaldehyde was used, namely, PLP with 0.5% PFA. 
Therefore, we favored the PLP with 0.5% PFA fixative and found that we could 
improve streptavidin penetration without detrimentally affecting morphology by 
increasing the incubation duration to 7 days (Figure 3.1E, E’). Perfusion fixation does not 
appear to be necessary to preserve morphology (compare Figure 3.1B, C) and it may 
hinder probe penetrance (compare Figure 3.1B’, C’), but because perfusion makes the 
tissue stiffer and, therefore, easier to section, we preferred to include this step for 
streptavidin-only labeling. We preferred to omit perfusion, however, on tissue that was 
labeled with antibodies in order to optimize their penetration into the spinal cord (see 
below). 
3.3.2 Tissue trimming 
In order to minimize the amount of tissue the confocal laser and fluorescent 
probes must penetrate, we used a vibratome to remove tissue dorsal and ventral to the 
spinal cord. We preferred to do this rather than dissect the cord out of the spinal column 
because dissection would disrupt the 3D relationships of a spinal cord injury site.  
To prepare for vibratome sectioning, segments of spinal column were decalcified 
with Morse’s solution and embedded in agarose. The agarose served as a support for the 
tissue during sectioning and in order for it to provide sufficient support, it needed to have 
a density similar to that of the spinal column. This is a challenge because spinal column 
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tissues have heterogeneous densities: the spinal cord is very soft compared to the muscle 
and decalcified bone around it. We tried 3%, 4%, and 6% agarose and found that, when 
sections are cut with thin, sharp blades, 4% worked best and enabled us to reliably obtain 
good sections. Agarose-embedded tissue blocks were glued onto vibratome chucks, 
ventral side down, and the dorsal tissue was trimmed until the spinal cord was exposed. A 
350 to 400 µm thick section was then cut which contained the entire spinal cord. The 
ventral side of the spinal cord was not always exposed in a 400 µm thick cut, but 
nonetheless this was adequate for streptavidin labeling. For antibody labeling, however, 
we preferred to risk losing a little of the ventral spinal cord to ensure that both sides were 
exposed and, therefore, cut 350 – 375 µm thick sections. It was not possible to obtain 
sections much thinner than about 100 µm because of the heterogeneous nature of the 
spinal column.  
3.3.3 Fluorescent Labeling 
Specific probes, such as antibodies and streptavidin, bind with high affinity to 
their specific binding sites and with low affinity to nonspecific sites. To obtain efficient, 
specific and even labeling of whole-mount preparations with such probes, specific 
binding sites must be made accessible throughout the tissue. Methods for making the 
tissue permeable to probes include the use of detergents, heat, enzymes, and carrier 
agents such as dimethyl sulfoxide (DMSO). At the same time, conditions for non-specific 
binding must be made unfavorable either with blocking reagents or by incubation at 
lower temperatures or both.  
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In initial experiments, we used phosphate buffered saline (PBS) with 0.5% of the 
detergent Triton X-100 and 20% of the carrier agent DMSO to permeabilize the newt 
spinal cord and incubated the sections at room temperature (RT) for 7 days. To block 
non-specific binding, we used 1% BSA and 0.1% fish gelatin. This was sufficient to 
allow the streptavidin probe to penetrate fully into a 400 µm section and label the axon 
tracer specifically with minimal background signal (Figure 3.1E). This was not sufficient, 
however, for antibody labeling. Using these same parameters and a 7d incubation with 
primary antibody followed by a 7d incubation with secondary antibody at RT, there were 
regions in the middle of the spinal cord that were not labeled with the 3A10 antibody, 
which is an axonal marker (Figure 3.2A).  
To improve antibody penetration, therefore, we tested whether increasing the 
amount or strength of the detergent could improve antibody labeling, compared to 0.5% 
Triton X-100, without detrimentally affecting morphology. We did not consider enzyme 
treatments, such as trypsin or collagenase, because we were interested in studying the 
expression of extracellular matrix proteins. Detergents tested, in order of increasing 
strength, were Tween-20 (weaker non-ionic), Triton X-100 (non-ionic), NP-40 (stronger 
non-ionic), CHAPS (zwitterionic), and SDS (ionic) (Bhairi and Mohan, 2007). SDS was 
only used during the pre-treatment period since it is a denaturing detergent. The 
detergents were evaluated in intact newt spinal cords that were labeled with the 3A10 
antibody and an antibody against glial fibrillary acidic protein (GFAP), which is an 
ependymoglial and astrocytic marker in the newt. None of the other detergents out-
performed Triton X-100. CHAPS and NP-40 worked about as well as similar 









Figure 3.2. Comparison of detergents and incubation times. A-O: 
Longitudinal sections of intact spinal cords were imaged through the 
dorsal-ventral axis, 3D-rendered in Fluorender and rotated to reveal cross 
sectional morphology. Dorsal is up. Axons were labeled with the 3A10 
antibody (green) and nuclei with SYTOX green (magenta). Headings 
above each panel indicate the amount and type of detergent used to 
permeabilize the section (Tx, Triton X-100; NP40, NP-40; CHP, CHAPS; 
SDS, SDS; Tw, Tween-20), the incubation times with primary and 
secondary antibodies (10/7 indicates 10 days with primary and 7 days with 
secondary), and whether the tissue was perfused (P) or not perfused (NP). 
Headings to left of each row group images into their respective 
experiments. Details of each experiment are summarized in Table 3.2. SA, 
streptavidin; cc, central canal; eg, ependymoglia; gm, grey matter; wm, 




expected, Tween-20 did not work as well (compare Figure 3.2K with O). SDS disrupted 
the morphology of the spinal cord, in that the cord appeared stretched and warped, 
without improving antibody penetration (Figure 3.2I).  
Thus, Triton X-100 remained our detergent of choice and we were able to 
modestly improve antibody penetration by increasing the amount of Triton X-100 to 2% 
(compare Figure 3.2A and F). This, however, was still not sufficient. In order to get 
labeling throughout the spinal cord, we increased incubation times to 10 days with 
primary and 10 days with secondary antibodies and improved the ability of the antibody 
solution to mix with the sections by incubating sections in higher volumes of antibody 
solution and in small centrifuge tubes, rather than in 96-well plates (Figure 3.2J-L). In 
fact, these adjustments appeared to have a greater effect on antibody penetrance than the 
amount of detergent, for these conditions enabled full penetrance with even 0.5% Triton 
X-100 (Figure 3.2L). The quality of labeling, though, was best with 2% Triton X-100. 
The fine GFAP positive processes emanating from ependymoglia and astrocytes are most 
clearly labeled in sections permeabilized with 2% Triton X-100 (compare Figure 3.3A-
C). 
Given that secondary antibodies often require less incubation time than primary 
antibodies, we tested whether this might be true in our sections. We permeabilized 
sections with 2% Triton X-100 and incubated them with primary antibody for 10 days 
and compared secondary incubation times of 3, 7 and 10 days. While antibody 
penetration was complete for all three time points (Figure 3.2J, M, N), the quality of 
labeling was best when incubation with secondary antibody was 10 days (compare GFAP 










Figure 3.3. Comparison of the quality of antibody labeling in experiment 
3. A-E: Single confocal planes, representing longitudinal sections through 
intact spinal cords at the level of the central canal (cc). Rostral is up. 
Axons were labeled with the 3A10 antibody (red), astrocytes and 
ependymoglia (eg) with a GFAP antibody (green), and nuclei with 
SYTOX green (blue). gm, grey matter; wm, white matter. Headings above 
each panel indicate the amount of Triton X-100 (Tx) detergent used to 
permeabilize the section and the incubation times with primary and 
secondary antibodies (10/7 indicates 10 days with primary and 7 days with 
secondary). Details of experiment 3 are summarized in Table 3.2. R, 






These results are summarized in Table 3.2. We optimized antibody labeling by 
increasing the amount of Triton X-100 detergent to 2%, increasing the incubation times 
to 10 days each with primary and secondary antibody, and improving the ability of the 
antibody solution to mix with the sections. This increased signal without adding 
background noise and without detrimental effects to morphology. Permeabilizing the 
tissue at a higher temperature (37°C) before the addition of antibodies did not appear to 
have a large effect on the efficiency of antibody penetration. Other factors that likely 
promote antibody labeling include decreasing the section thickness to 350 – 375 µm to 
ensure that the spinal cord is exposed on both sides of the section and omitting the 
perfusion fixation step and fixing the tissue after harvest only.  
3.3.4 Clearing 
Whole-mount specimens must be free of light scattering pigment and optically 
clear before high-quality confocal images through the entire specimen can be obtained. 
For this, bleaching and clearing agents are used (Klymkowsky and Hanken, 1991).  
We tried two types of bleach, a modified Dent’s bleach containing 15% hydrogen 
peroxide and a formamide bleach containing 6% hydrogen peroxide and 3% formamide. 
The formamide bleach was superior. All pigment was completely gone after just 2 hours 
in the formamide bleach while the Dent’s bleach was unable to remove all pigment even 
after a 2 day incubation period.  
To clear our whole-mounts, we tried glycerol and BABB. Despite the 
disadvantages to working with BABB, namely that it is a caustic solution and makes the 





Table 3.2. Amount of antibody penetrance obtained with various detergents and 
incubation times 
exp perfuse detergent  
thick-
ness 
1°  Ab 
time 




initial yes 0.5% Tx  400 µm 7d 7d fair – 
        
1 no 1% Tx  300 µm 3.5d 2d fair – 
1 yes 1% Tx  300 µm 3.5d 2d fair – 
1 no 1% NP40  400 µm 3.5d 2d fair – 
1 yes 1% NP40  400 µm 3.5d 2d fair – 
2 no 0.5% Chp 350 µm 5d 4.5d poor – 
2 no 1% Chp 350 µm 5d 4.5d fair – 
2 no 1% SDS in pre-tr, 
then 2% Tx 
350 µm 5d 4.5d fair poor 
morphology 
2 no 2% Tx  300 µm 5d 4.5d fair – 
3 no 0.5% Tw 350 µm 10d 10d fair – 
3 no 0.5% Tx 350 µm 10d 10d complete ok 
3 no 1% Tx 350 µm 10d 10d complete good 
3 no 2% Tx 350 µm 10d 3d complete ok 
3 no 2% Tx 350 µm 10d 7d complete good 
3 no 2% Tx 350 µm 10d 10d complete best 
Conditions for each experiment (exp) are listed below.  
Initial: permeabilize 2 hours, RT; incubate in 250 µl in 96-well plate 
Exp 1: permeabilize 2 hours, 37°C; incubate in 250 µl in 96-well plate 
Exp 2: permeabilize 5 hours, 37°C; incubate in 250 µl in 96-well plate 
Exp 3: permeabilize 4.5 hours, RT; incubate in 400 µl in small centrifuge tubes  




Care was taken to always wear gloves and avoid the use of plastics when working with 
BABB. Sections were transferred to glass vials before they were cleared. Cleared sections 
were transferred to metal slides for imaging and transferred back to the glass vials 
containing BABB for storage at 4°C. Sections stored in this way have remained well 
preserved for up to 2 years.  
3.3.5 Viewing 3D relationships 
As mentioned above, spinal cords were imaged on a confocal microscope in 2 to 5 
µm steps through the dorsal-ventral axis. 3D relationships were then visualized with 
ImageJ or Fluorender software. This is demonstrated on a 3-week regenerating spinal 
cord that was prepared with the optimized method outlined in Table 3.1 and labeled with 
the 3A10 antibody and an antibody against the extracellular matrix protein, tenascin C 
(TN-C). In ImageJ, the planes of the confocal z-stack can be viewed individually in rapid 
succession to allow one to visualize the detail in each confocal plane in relationship to the 
whole stack (Figure 3.4A-A”, Movie 3.1). Using this view, one can appreciate that some 
of the TN-C in this injured spinal cord lines tube-like structures that are connected 
(arrowheads in Figure 3.4A-A”). This type of 3D structure would not be as well 
appreciated if it were viewed in a single 2D image. In Fluorender, the whole volume is 
rendered in 3D and it can be rotated to reveal, for example, cross-sectional morphologies 
and 3D shapes (Figure 3.4B-B”, Movie 3.2).    
This method of visualizing the cellular and molecular structure of the regenerating 
newt spinal cord represents a significant advance in the field of newt regeneration 










Figure 3.4. Visualizing 3D relationships. A 3-week regenerating spinal 
cord was prepared for antibody labeling as outlined in Table 3.1 and 
longitudinal planes through the dorsal-ventral axis were imaged on a 
confocal microscope. Axons were labeled with the 3A10 antibody (red), 
the extracellular matrix with a TN-C antibody (green), and nuclei with 
SYTOX green (blue). Rostral is up. A-A”: Single confocal planes through 
the level of the terminal vesicles (TV, A), and 40 µm (A’) and 60 µm (A”) 
dorsal to the TVs. The arrowheads mark TN-C-lined, tube-like structures 
that can be seen to be connected when the whole z-stack is viewed (Movie 
3.1). The asterisk marks the injury site. B-B”: Snapshots of Movie 3.2 of 
the entire z-stack rendered in 3D with Fluorender and rotated around the 
horizontal axis. B: A dorsal view rotated 20° to reveal a cross section of 
the spinal cord caudal to the injury (arrow). B’: A flat dorsal view. B”: A 
dorsal view rotated 20° to reveal a cross section of the spinal cord rostral 
to the injury (arrow). Scale bars: 100 µm (A-A” are the same scale).  
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regeneration. These methods should also be widely adaptable for anyone wishing to study 
3D relationships in other adult tissues. 
3.4 Detailed methods 
3.4.1 Animals 
Adult newts, Notophthalmus viridescens, were purchased from Charles D. 
Sullivan Co. Inc., (Nashville, TN), housed at 22°C in glass aquariums equipped with 
water filters, and fed live blackworms, Lumbriculus varietgatus (Eastern Aquatics, PA). 
All animal protocols were approved by the University of Utah Institutional Animal Care 
and Use Committee. 
3.4.2 Spinal cord injury surgery 
Transect the spinal cord and allow it to regenerate for the desired length of time, if 
applicable. Perform transection injuries as described in Davis et al (1989; 1990). 
Anesthetize newts in Tricaine solution for 10 min and then place in ice for 30 min. Place 
the animal prone on a sylgard dish with its trunk region propped up slightly. Cover the 
head and tail with moist kimwipes. Swab the skin with 10% providone iodine and make a 
deep incision between two vertebral bones about 1 cm rostral to the hindlimbs. Using 
forceps, gently separate the vertebrae and remove the dorsal lamina of the caudal-most 
vertebra to expose the spinal cord. Cut the cord completely with fine spring scissors. 
Irrigate blood with sterile 85% PBS, if necessary. Place newts on ice for 15 min after the 
surgery and allow them to recover in bins that are tilted to produce a shallow area of 
water. Clean bins every day or two during the recovery period and replace the water with 
fresh de-chlorinated tap water. 
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3.4.3 Tissue preparation 
3.4.3.1 Day 1 (Apply axon tracer, harvest tissue, and fix). 
1. Apply the axon tracer to the spinal cord and allow it to travel for 6 hours, if 
applicable. Our procedure was modified from that used in zebrafish (Becker et al., 1997; 
Becker and Becker, 2001). Prepare tracer-soaked pieces of gel foam ahead of time: soak a 
small piece of gel foam in 1.5 µl of a 10% solution of biotinylated dextran amine (BDA, 
3kD, lysine fixable, Invitrogen, D7135) and let it air dry in a tissue culture hood for 40 
min to further concentrate the solution. Add fast green dye (Fisher, F-99) to the tracer 
solution at 0.05 mg/ml to make it visible in vivo, if desired. To apply the tracer, 
anesthetize newts as above and place in ice for 30 min. Transect the spinal cord as above 
one segment rostral or caudal to the original injury site (or targeted injury site if the cord 
is still intact) and insert a piece of tracer-soaked gel foam into the wound. Control 
excessive bleeding before adding the tracer, if necessary, by inserting a piece of fresh gel 
foam into the wound and allowing the animal to sit on ice for a few minutes. Minimize 
use of this technique as it decreases the efficiency of tracer uptake. 
2. Once the tracer dye has labeled the spinal cord, perfuse the newts through the 
heart with 1.5 ml 85% PBS followed by 3 ml PLP with 0.5% PFA (omit if labeling with 
antibodies). We use a micromanipulator to control the needle and an infusion pump set to 
run at about 1 ml per 1.5 min. Anesthetize newts in Tricaine solution for 10 min and then 
place on ice for 15 min. To perfuse, place the newt supine on a sylgard dish and pin the 
arms apart. Make a rostral-caudal incision between the forelimbs up to the jaw/neck to 
expose the heart. Position the perfusion needle near the heart, turn on the perfusion pump 
to run 85% PBS, nick the sinus venosus and insert the needle into the ventricle. After 1.5 
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ml of 85% PBS has run through the animal, switch the pump to the fixative and run 3 ml 
of it through the animal. The liver should be cleared of blood and the animal should feel 
stiff after perfusion. 
3. Harvest about 4 mm of lower trunk spinal column. If the animal has not been 
perfused, then sacrifice via decapitation after the animal is fully anesthetized. Use a 
microtome blade (extremely sharp; Ted Pella, 27237, Accu-Edge blades) to separate 
about 4 mm of the lower trunk spinal column from the rest of the spinal column and 
scissors to remove the 4 mm long segment from the rest of the animal. Trim away tissue 
lateral to the spinal column so that the specimen is about 2 mm wide. Always use a very 
sharp blade when cutting or trimming the spinal column so that you do not pull the very 
soft spinal cord out of the spinal column.  
Note: All incubations are at RT and with rocking unless otherwise specified. 
4. Post-fix in PLP with 0.5% PFA for 2 hours. Use 3 ml in a small vial if fixing 1 
or 2 segments together. Use 10 ml in 15 ml conical tube if fixing 3 to 8 segments 
together.  
5. Rinse with PBS briefly, then for 30 min (3 times), then overnight at 4°C. 
3.4.3.2 Day 2 (Decalcify). 
6. Decalcify with Morse’s solution for 24 hours. 
3.4.3.3 Day3 (Bleach, embed, section, permeabilize). 
7. Rinse with PBS briefly, then for 30 min (3 times). 
8. Bleach with formamide bleach for 2 hours or until all pigment is gone.  
9. Rinse with PBS briefly, then for 30 min (3 times). 
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10. Embed in 4% agarose for longitudinal sections. Dissolve agarose in PBS by 
heating in a microwave and stabilize the temperature to 60°C in an oven prior to 
embedding. Keep agarose liquefied during embedding by putting it on a hot plate at the 
bench. Dab tissue on a kimwipe, fill the mold with agarose, quickly position the tissue in 
the mold, and place the mold on ice to let the agarose congeal. 
11. Use a vibratome to obtain thick sections containing the entire spinal cord. Fill 
the collection bath with pre-chilled PBS and keep it cold with PBS ice cubes. Use feather 
thin blades (Ted Pella, 121-6, Double Edge, Breakable Style) rather than razor blades to 
section and always use a fresh part of the blade for each block. Remove agarose block 
from the mold, trim, and use Super Glue to glue the block to the chuck so that the ventral 
side of the spinal column is down. We used a Leica VT1000S vibratome and set the 
speed to 6.5 (out of 10) and the amplitude to 9 (out of 10). Trim the dorsal tissue until the 
spinal cord is exposed. Set the machine to cut a 400 µm (for streptavidin only labeling) or 
a 350-375 µm (for antibody labeling) thick section that contains the whole spinal cord. 
The spinal cord should be exposed on both sides for antibody labeling. Trim agarose 
away from the sides of the section and transfer the section to a small centrifuge tube 
containing PBS. 
3.4.4 Fluorescent labeling 
Note: Use at least 400 µl per small centrifuge tube. PBS-TxD or PBS-TxDB 
solutions should be made fresh and have 0.5% Triton X-100 for streptavidin staining and 
2% Triton X-100 for antibody staining. If labeling with both streptavidin and antibodies, 
then use the parameters for antibody labeling. 
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12. Permeabilize with PBS-TxD for 4 hours to overnight.  
13. Incubate in streptavidin-Cy5 or primary antibody diluted in PBS-TxDB for 7 
or 10 days, respectively. 
14. Rinse with PBS-Tx briefly, then for 30 min (5 times). 
15. Incubate in secondary antibody diluted in PBS-TxDB for 10 days.  
16. Rinse with PBS-Tx briefly, then for 30 min (4 times). Then rinse with TNT 
for 30 min. 
17. Incubate in SYTOX green solution for 2-3 hours to stain nuclei.  
3.4.5 Dehydration and clearing 
18. Rinse with TN for 10 min (3 times) and transfer sections to glass vials. 
19. Dehydrate through a methanol (MeOH)/TN series: 20%, 50%, 75%, 100% 
MeOH, 15 min each. These times are critical. Once dehydrated, move sections into the 
clearing agent as soon as possible. 
20. Clear with BABB (1 part benzyl alcohol, 2 parts benyzl benzoate) and store in 
BABB at 4°C. When working with BABB, wear gloves and do not use plastics. Dispose 
of used BABB via incineration. 
3.4.6 Confocal imaging and image analysis 
The metal slides made for imaging are 77 x 26 mm2 and 1 mm thick and have a 
13 mm diameter hole drilled through the center. A glass coverslip covers the hole on one 
side to create a well and is glued in place with clear nail polish. Before imaging, dump a 
cleared section and the BABB in which it is stored into a glass petri dish, and use forceps 
to transfer the section to the well in the metal slide. Use a glass pipette to fill the well 
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with BABB, and cover the well with another coverslip. Transfer the remaining BABB 
back into the glass vial. After imaging, remove the top coverslip and transfer the section 
back to the BABB in the glass vial for storage at 4°C. 
Spinal cords were imaged on an Olympus FV300 laser scanning confocal 
microscope using a 20X air objective. Images were processed with ImageJ, version 1.40g 
(W. Rasband; http://rsb.info.nih.gov/ij; NIH, Bethesda, MD), Fluorender, version 2.5.0 
(Otsuna and Wan; http://www.sci.utah.edu/software/13-software/127-fluorender.html; 
University of Utah, Salt Lake City, UT) and Adobe Photoshop CS2. Levels were adjusted 
in ImageJ and/or Photoshop to maximize the signal to noise ratio.  
3.4.7 Solutions 
Tricaine solution: 0.1% w/v Tricaine (Ethyl 3-aminobenzoate methanesulfonate 
salt, Sigma, A5040) in 20 mM Tris-HCl, pH 7.5. 
PBS: 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.15 mM KH2PO4, pH 7.4. 
PLP fixative: 75 mM lysine, 0.5-2% PFA, 10 mM NaIO4 in 85% PBS. Prepare by 
mixing 3 parts 0.1 M lysine stock with 1 part 4X PFA, then add solid NaIO4. Make fresh 
and use within 2 hours. Make stock solutions ahead of time and store at -20°C: 0.1 M 
lysine in 85% PBS; 16% PFA in 85% PBS, pH 7.4.  
GA/PFA fixative: 2% GA, 2% PFA in 85% PBS, pH 7.4. 
Morse’s solution: 22.5% formic acid, 10% sodium citrate. 
Formamide bleach: 6% H2O2, 3% formamide, 0.1% Triton X-100 in PBS. 
Modified Dent’s bleach: 15% H2O2, 40% MeOH, 10% DMSO. 
PBS-TxD: PBS with 0.5% or 2% Triton X-100 and 20% DMSO. 
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PBS-TxDB: PBS-TxD with the blocking reagents 1% BSA (EMD, OmniPur, 
Fraction V, Heat Shock Isolation, 2960) and 0.1% fish skin gelatin (Sigma G7765, 45% 
solution). 
TN: 100 mM Tris-HCl, pH 7.5, 150 mM NaCl. 
TNT: TN with 0.05% Tween-20 
SYTOX green solution: Dilute SYTOX green (Invitrogen, S7020) 1:1000 in 
DMSO to make a stock solution and store at -20°C. Before use, dilute the stock another 
1:25 in TNT.  
3.4.8 Antibodies and streptavidin 
Primary antibodies and dilutions used are as follows: 3A10 (mouse anti-chick 
neurofilament associated protein IgG1 monoclonal, DSHB, 3A10) 1:25; GFAP (rabbit 
anti-cow GFAP polyclonal, Dako, Z0334), 1:200; TN-C (rabbit anti-chick tenascin C 
polyclonal, Chemicon, AB19013) 1:100. Secondary antibodies (Invitrogen, whole 
antibodies, 2 mg/ml, conjugated to Alexa 568 or 633) were diluted 1:100. Streptavidin-
Cy5 (Invitrogen, SA1011) and Streptavidin-Alexa 633 (Invitrogen, S21375) were diluted 
to 4 µg/ml. Lyophilized streptavidin-Alexa 633 was reconstituted with PBS to make a 1 
mg/ml stock. 
3.5 Movie legends 
Movie 3.1. Movie through whole confocal z-stack of the 3 week 
regenerate shown in Figure 3.4A-A”. It begins on the ventral side of the 
cord and moves in 2 µm increments through to the dorsal side. Rostral is 
up. Axons were labeled with the 3A10 antibody (red), the extracellular 
matrix with a TN-C antibody (green), and nuclei with SYTOX green 
(blue).  
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Movie 3.2. A movie of the Fluorender 3D rendering of the 3 week 
regenerate shown in Figure 3.4B-B”. Axons were labeled with the 3A10 
antibody (red), the extracellular matrix with a TN-C antibody (green), and 
nuclei with SYTOX green (blue). It begins with a dorsal view in which 
rostral is up. Scale bar: 100 µm. 
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CHAPTER 4 
MENINGEAL CELLS AND GLIA ESTABLISH A PERMISSIVE 
ENVIRONMENT FOR AXON REGENERATION  
AFTER SPINAL CORD INJURY IN NEWTS 
4.1 Abstract 
4.1.1 Background 
Newts have the remarkable ability to regenerate their spinal cords as adults. Their 
spinal cords regenerate with the regenerating tail after tail amputation, as well as after a 
gap-inducing spinal cord injury (SCI) such as a complete transection. While most studies 
on newt spinal cord regeneration have focused on events occurring after tail amputation, 
less attention has been given to events occurring after an SCI, a context that is more 
relevant to human SCI. Our goal was to use modern labeling and imaging techniques to 
observe axons regenerating across a complete transection injury and determine how cells 
and the extracellular matrix in the injury site might contribute to the regenerative process.
4.1.2 Results 
We identify stages of axon regeneration following a spinal cord transection and 
find that axon regrowth across the lesion appears to be enabled, in part, because 
meningeal cells and glia form a permissive environment for axon regeneration. 
Meningeal and endothelial cells regenerate into the lesion first and are associated with a 




paradoxically, consists of both permissive and inhibitory proteins. Axons grow into the 
injury site next and are closely associated with meningeal cells and glial processes 
extending from cell bodies surrounding the central canal. Later, ependymal tubes lined 
with glia extend into the lesion as well. Finally, the meningeal cells, axons, and glia move 
as a unit to close the gap in the spinal cord. After crossing the injury site, axons travel 
through white matter to reach synaptic targets, and though ascending axons regenerate, 
sensory axons do not appear to be among them. This entire regenerative process occurs 
even in the presence of an inflammatory response. 
4.1.3 Conclusions 
These data reveal, in detail, the cellular and extracellular events that occur during 
newt spinal cord regeneration after a transection injury and uncover an important role for 
meningeal and glial cells in facilitating axon regeneration. Given that these cell types 
interact to form inhibitory barriers in mammals, identifying the mechanisms underlying 
their permissive behaviors in the newt will provide new insights for improving spinal 
cord regeneration in mammals. 
4.2 Background 
Unlike mammals, adult newts have the remarkable ability to recover function 
after they are paralyzed by a spinal cord injury (SCI). After a complete transection injury, 
newts regenerate their spinal cords and regain use of their hindlimbs in as little as 4 wks 
(Davis et al., 1990) (see Movie 4.1). This recovery requires supraspinal axons to 
regenerate across the lesion and re-establish connections with downstream targets and is 




This finding led us to ask the question: why do axons regenerate across an injury site in 
the newt when they do not in mammals? 
One of the main reasons why regeneration fails in mammals is because the 
environment of the injured spinal cord is inhibitory for axon regeneration (Silver and 
Miller, 2004).  After SCI, a variety of cell types, including astrocytes and meningeal 
fibroblasts, react in ways that prevent axons from regenerating across the injury site. 
These reactive cells create physical barriers to regeneration such as a glial scar and a glial 
limitans at the border between the cord and the injury site. They also create an 
extracellular matrix (ECM) that is inhibitory or repulsive for axon growth cone 
migration.  
Therefore, axon regeneration may be enabled in the newt, in part, because the 
environment of the injury site is not inhibitory. Cells may respond in ways that help 
rather than hinder axon regeneration such that physical barriers are not created and the 
ECM is not inhibitory. 
Much of what is known about spinal cord regeneration in salamanders comes 
from studies of tail regeneration. After tail amputation, a blastema forms and 
ependymoglia (EG) lining the central canal of the spinal cord elongate an ependymal tube 
that precedes and serves as scaffold for axon regeneration (Singer et al., 1979). 
Regeneration in this context is thought to proceed as a recapitulation of developmental 
processes as axons grow into newly developing tissues. Surprisingly, little is known 
about how axons regenerate after an SCI in the newt. In this context, axons must re-grow 
through an injury site having mature tissues on both sides of the lesion. This context is 




newt have noted that a blastema and glial scar do not appear to form (Piatt, 1955), that 
axons can bridge large gaps in the cord before ependymal tubes elongate (Butler and 
Ward, 1967), and that, if left intact, the meninges can serve as a scaffold for axon 
regeneration (Stensaas, 1983). A more recent study of SCI in the axolotl, a neotenic 
larval salamander, found that EG appear to undergo an epithelial to mesenchymal 
transition, migrate into the injury site to form a solid mass, and then undergo a 
mesenchymal to epithelial transition to re-form an ependymal tube that serves as a 
scaffold for axon regeneration (O'Hara et al., 1992; Chernoff et al., 2003). In summary, 
previous studies suggest that physical barriers do not appear to form and EG and the 
meninges may help axons regenerate. Though O’Hare et al (1992) demonstrated that 
mesenchymal cells in the axolotl injury site were associated with fibronectin (FN), a 
permissive ECM protein, little else is known about the nature of the ECM of the injured 
newt spinal cord.  
A focused and detailed study of axon regeneration and the cellular and 
extracellular environment axons encounter after an SCI in the newt has not been 
conducted. We, therefore, took advantage of modern labeling and imaging techniques to 
define, for the first time, stages of newt axon regeneration after a spinal cord transection 
injury and find that meningeal cells and glia, instead of interacting to form barriers to 
axon regeneration as they do in mammals (Shearer and Fawcett, 2001; Bundesen et al., 
2003), appear to interact to form a permissive environment for axon regeneration in the 
newt. Our study examines many aspects of newt spinal cord regeneration, establishes the 




controlling this naturally occurring process, and may inform new therapeutic approaches 
in regenerative medicine. 
4.3 Results and discussion 
To understand how newt axons regenerate after an SCI we carefully observed 
axons regenerating across a complete transection injury, which severed all innervation to 
the tail and hindlimbs. Animals were allowed to regenerate for 1 d, 3 d, 1 wk, 2 wks, 3 
wks, 4 wks, 6 wks or 9 wks, and prior to tissue harvest an axon tracer was applied rostral 
or caudal to the original injury site in order to label descending or ascending regenerating 
axons, respectively. The tracer and nuclei were labeled fluorescently, and the injury site 
was analyzed in whole-mount preparation on a confocal microscope. At least 3 animals 
were observed per tracer application site and time point (Table 4.1).  
4.3.1 Spinal cord transection injury and axon tracer application 
The spinal column in Notophthalmus viridescens contains one cervical (the atlas), 
about 13 trunk, 1-2 sacral, and 22-25 caudal vertebrae (Figure 4.1A) (Francis, 2002). The 
number of trunk, sacral and caudal vertebrae appears to be variable. The hindlimbs are 
innervated primarily by the last 2 trunk (T-1 and T-2) and first sacral (S1) spinal nerves, 
though there can be contributions from the third to last trunk (T-3) vertebra and the 
vertebra after S1 (S2/C1) (Figure 4.1D) (Francis, 2002).  This is supported by the fact 
that the largest spinal nerves are associated with T-2, T-1 and S (see Figure S4.1) and 
axon tracer applied to the sciatic nerve labels primarily neurons in these spinal ganglia 
(see Figure 4.3A, B). To be sure all innervation to the hindlimbs was severed, we aimed 
to transect the spinal cord between T-4 and T-3 (Figure 4.1A, D), about 1 cm rostral to 
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* The numbers in parentheses break the totals for each category into rostral and caudal tracer 
application, respectively. For example, (4/2) indicates 4 animals received rostral tracer and 2 
received caudal tracer. Animals that had recovered function were chosen preferentially for rostral 

















Figure 4.1. Spinal cord transection injury and axon tracer application. (A) 
Newt skeleton showing targeted location of injury. Note, the sacroiliac 
(SI) joints are not associated with the same vertebra in this animal, thus 
there are two sacral (S) vertebrae where there is usually one. T, trunk; C, 
caudal. (B) Intact and (C) completely transected spinal cord viewed from 
dorsal side. (D) Cartoon showing the location of the targeted injury, the 
spinal ganglia that supply innervation to the hindlimbs (solid line, primary 
contribution; dotted line, occasional contribution), and rostral tracer 
application site. (E) Cross section of spinal cord about 500 µm away from 
a tracer application site showing the tracer labels axons and neurons 
specifically. (F, G) Longitudinal sections through 1 wk regenerates. 
Asterisk, injury site. The tracer was applied to the animal in (F) and not to 
the animal in (G). Axons were also labeled with the 3A10 antibody. 
Application of the tracer 6 hours prior to tissue harvest did not alter the 
overall appearance of the axons at the injury site. cc, central canal; eg, 
ependymoglia; gm, grey matter; wm, white matter; m, meninges; D, 








the hindlimbs. Upon dissection, it was often found that the injury was actually 1 or 2 
segments rostral to the targeted site (see Figure S4.1B). Figure 4.1B shows what the 
intact spinal cord looks like when exposed from the dorsal side. After a complete 
transection injury, the two ends of the cut cord spring away from each other leaving a gap 
in the cord (Figure 4.1C). This type of injury was chosen because it is simple to perform 
consistently, spares no axons, severs the meninges as well as axons, and allows our 
studies to more seamlessly complement those done by previous investigators (Piatt, 1955; 
Davis et al., 1989; 1990). All injured animals were paralyzed (see Movie 4.1) and unable 
to swim for at least 3 wks, though the typical reflexive movements of the hindlimbs and 
tail were observed. Recovery of swimming function was scored and filmed in 6 and 9 wk 
regenerates. One out of seven (14%) 6 wk regenerates and 4 /6 (67%) 9 wk regenerates 
recovered swimming function (Table 4.1). This recovery rate is consistent with that 
reported in Davis et al (1990). 
To label descending regenerating axons, a piece of gel foam saturated with the 
axon tracer, biotinylated dextran amine (BDA) was inserted into a transection injury 1 
segment (about 2 mm) rostral to the original injury site (Figure 4.1D), and the tracer was 
allowed to travel for 6 hours. Ascending axons were similarly labeled by applying the 
tracer 1 segment caudal to the original injury. BDA travels 3 – 4 mm in 6 hours (see 
Figure 4.2K, L), produces a strong signal, and labels only neurons and their processes in 
the nervous system (Figure 4.1E). It does not diffuse across an injury site to label axons 
that have not regenerated across it (see Figure 4.2A-D). Transecting the spinal cord to 




harvest does not appear to alter the general appearance of axons in the injury site 
(compare Figure 4.1F and G; see also Figure 4.4F, J, N, R vs. B, V).  
4.3.2 Stages of axon regeneration 
Our tracer analyses uncovered six stages of axon regeneration (Figure 4.2) that 
appeared to be typical and sequential. The timing for all but the first two stages was 
highly variable (Table 4.1). The times in parentheses after each stage in the text indicate 
the earliest and latest time points at which the stage was observed. 
4.3.2.1 Retraction stage (1 d – 1 wk, most often before 1 wk)   
Axons appear to have retracted away from the end of the cut cord (Figure 4.2A, 
B), and many axon tips have a balled-up morphology that is reminiscent of the dystrophic 
end-bulbs seen on axons that are unable to regenerate (Figure 4.2B”) (Ramon y Cajal, 
1928; Tom et al., 2004). Axon growth cones, however, can also be identified at this stage 
(Figure 4.2B’).   
4.3.2.2 Growth initiation stage (3 d – 2 wk, most often at 1 wk)  
Axons appear to have initiated growth and grown back to the end of the cut cord 
(Figure 4.2C, D). As in the retraction stage, dystrophic axons and growth cones can be 
identified (Figure 4.2D’, D”). The main difference between the first two stages is that 
many more axons extend to the end of the cut cord in the growth initiation stage. This 
difference is apparent even when all axons from the spinal cord are viewed in z-
projections (see Figure S4.2). Also in this stage, the central canal, especially on the 












Figure 4.2. Stages of axon regeneration. Images are montages of single 
confocal planes (except where indicated) of longitudinal thick sections. 
Rostral is to the left. Descending (A, C, E, G, I, K) or ascending (B, D, F, 
H, J, L) axons were labeled with the axon tracer (magenta), and nuclei are 
shown in green. Time after injury is indicated in the upper right corner of 
each panel. (A, B) Retraction and (C, D) growth initiation stages. 
Arrowheads, end of cord; asterisk, injury site; dotted line, unlabeled cord 
opposite the injury site. (B) is a z-projection of 4 planes to highlight 
growth cones. (B’, B”, D’, D”) Enlargements of dotted boxes in (B) and 
(D) showing that growth cones (primed boxes) and dystrophic axons 
(double primed boxes) are present at both stages. (E, F) Wrapping stage. 
(G, H) Wisping stage. (I, J) Spiking stage. (H) and (I) are z-projections of 
2 confocal planes to show wrapping axons with wisping (H) or spiking (I) 
axons. (K, L) Contact and growth beyond the injury site stage. The animal 
in (K) had recovered swimming function, while the one in (L) had not. 
Open arrowheads, residual wrapping axons; arrows, meninges; TV, 
terminal vesicle. R, rostral; C, caudal. Scale bars: 200 µm (A-L), 50 µm 







4.3.2.3 Wrapping stage (2 wk – 4 wk) 
Axons continue to grow and wrap around the end of the TV (Figure 4.2E, F). 
Residual numbers of dystrophic axons can still be seen at this and all subsequent stages. 
The meninges also wrap around, or bound, the end of the cord (Figure 4.2E, F) and often 
begin regenerating across the injury site ahead of the axons and TV (Figure 4.2F). The 
low density of cells within the injury site suggests that a scar is not forming. The size of 
the gap in the cord is also larger at this stage than at all other stages (see Figure S4.3). 
This could indicate that the wrapping stage is an abortive stage seen only in animals that 
do not recover function. We do not favor this interpretation, however, because wrapping 
axons are still evident at all subsequent stages. This observation suggests that wrapping is 
a typical stage through which all regenerating spinal cords progress. The gap in the cord 
may get bigger before it gets smaller, simply as a result of body movements of the 
animal. 
4.3.2.4 Wisping stage (2 wk – 6 wk)  
Axons begin growing, or wisping, into the injury site ahead of the EG-lined TV 
(Figure 4.2G, H). Thus, as seen in previous studies of SCI in the newt, a pre-formed 
ependymal tube is not required for axon regeneration into the injury site (Butler and 
Ward, 1967; Stensaas, 1983). Wisping axons, however, do not grow into the ECM of the 
injury site alone but rather remain associated with cells. Many of these cells appear to be 
continuous with the meninges. At this stage, the meninges do not bound the end of the 
cord as they did in the wrapping stage but continue regenerating across the injury site, 
preceding the regenerating axons. Some wisping axons even appear to follow the 




4.3.2.5 Spiking stage (3 wk – 6 wk) 
As wisping axons continue to grow, they may fasciculate to form a spike (Figure 
4.2I, J; see also Movies 4.3, 4.4). Spiking axons are still associated with cells in the injury 
site and cells that are continuous with the meninges. Some spikes do not contain an 
ependymal tube (Figure 4.2J), while others do (Figure 4.2I). In spikes with an ependymal 
tube, the ependymal tube appears to have elongated from the end of the cut cord because 
the largest part of the TV and residual wrapping axons are seen well behind the tip of the 
spike (Figure 4.2I; see also Movie 4.4). It is conceivable that a spike may not need to 
form. For example, if the gap in the cord is not large, wisping axons may be able to grow 
through the lesion and enter the cord on the opposite side without forming a spike. 
4.3.2.6 Contact and growth beyond the injury site stage (3 wk – 9 wk) 
In this stage, the two ends of the cord make contact with each other, and axons 
begin growing through the cord on the opposite side of the injury to re-establish 
functional connections (Figure 4.2K, L). All animals that had recovered swimming ability 
were in this stage, although not all animals in this stage had recovered function. Also, in 
all animals that had recovered, the ependymal tubes on each side of the injury had fused 
together to re-establish a continuous central canal. It was not possible to correlate the 
distance axons had regenerated beyond the injury site with functional recovery in this 
study because the axon tracer appears to fade out after 3 - 4 mm (Figure 4.2K, L). This is 
true even in the intact spinal cord (data not shown). There is some tolerance for 
sloppiness in how axons regenerate, for even in animals that had recovered function, 
wrapping axons were still evident (see Figure S4.4A” and Movie 4.5), some axons 




be seen traveling along the meninges (Figure 4.2K). Excessive sloppiness or gross 
misalignments may be the cause of a delay in or a complete failure of functional recovery 
(see Figure S4.4B-F and Movie 4.6).  
4.3.3 Sensory axons do not appear to regenerate 
Descending and ascending regenerating axons appear to progress through similar 
stages (Table 4.1, see also Table S4.1). This was surprising given that sensory axons are 
not thought to regenerate after a SCI in newts or zebrafish even though these animals 
recover function (Stensaas, 1983; Becker et al., 1997). To determine if ascending 
regenerating axons are true sensory axons, rather than axons arising from neurons within 
the spinal cord, an axon tracer was applied to the sciatic nerve 1 or 4 days prior to tissue 
harvest (Figure 4.3A). In 6 wk regenerates, descending axons were also labeled with a 
different tracer. Our goal was to identify tracer-labeled sensory axons wisping into and 
growing through and beyond the lesion.   
Tracer application to the sciatic nerve effectively labels, on the ipsilateral side 
only, sensory neurons in the spinal ganglia, motor neurons, dorsal column axons, and 
occasionally axons in a ventral location, which are presumably motor neuron axons 
exiting the cord to form the ventral root (Figure 4.3B). Labeled sensory and motor 
neurons were found mostly at the level of S1 and T-1 and occasionally at T-2 (Figure 
4.3A).   
To determine if sensory axons are among axons wisping into the injury site, 3 wk 
regenerates received tracer application to the sciatic nerve 4 days prior to tissue harvest 
(n=3). The spinal cord caudal to the injury site (T-2 to S1) was analyzed in cross section 









Figure 4.3. Sensory axons may not regenerate. (A) Cartoon showing 
tracer application sites in relationship to the SCI. Tracer was applied to the 
sciatic nerve in the hindlimb to label sensory axons (green) and, in 6 wk 
regenerates, rostral to the injury to label descending axons (magenta). 
Tracer applied to the sciatic nerve labels primarily neurons in spinal 
ganglia S1 and T-1 (solid lines) and occasionally neurons in T-2 (dotted 
lines). (B) Cross section through spinal cord and spinal ganglia at T-1, 1 
day after SCI and tracer application to the sciatic nerve. The tracer labels 
sensory neurons in the spinal ganglia (sg), motor neurons (mn), dorsal 
column axons (dc), and motor neuron axons (mna) exiting to form the 
ventral root. (C-E) Sections through a 3 wk regenerate. Sensory axons 
were labeled with BDA (green), and all axons were labeled with 3A10 
(magenta in D, E). (C) Cross section at T-1. Inset, spinal ganglia on 
labeled side. (D, E) Longitudinal sections through the SCI at the level of 
the dorsal columns (D), and a more ventral level where there are wisping 
axons (E). Schematic cross sections of the spinal cord in the upper right 
corner show where the section is along the D-V axis. (F-H) Cross sections 
through a 6 wk regenerate that had recovered swimming function at T-1 
(F), at T-4, about 500 µm caudal to the SCI (G), and through the center of 
the SCI at T-4/T-5 (H). Sensory axons were labeled with RDA (green), 
and descending axons were labeled with BDA (magenta). Inset in (F), 
spinal ganglia on labeled side. Inset in (H), phase image of injury site. 
Nuclei are shown in blue. D, dorsal; V, ventral; R, rostral; C, caudal. All 









dorsal column axons were labeled in all three animals (Figure 4.3C). The injury site was 
analyzed in longitudinal sections to best view wisping axons. In sections through the 
dorsal columns, tracer-labeled sensory axons could be seen all the way up to the end of 
the cut cord (n = 2 out of 3; Figure 4.3D). In ventral sections through the region of 
wisping axons, however, none of the wisping axons were labeled with the tracer (Figure 
4.3E).  
To determine if sensory axons grow through and beyond an injury site, 6 wk 
regenerates received rhodamine dextran anime (RDA) application to the sciatic nerve 4 
days prior to tissue harvest. BDA was also used to label descending axons. The spinal 
cord caudal to the lesion and the lesion itself were analyzed in cross section (n = 4). 
Sensory and motor neurons and dorsal column axons were effectively labeled with RDA 
in the spinal cord caudal to the lesion in three out of the four animals (Figure 4.3F). Two 
of the animals in which RDA was effectively applied had recovered function, and BDA-
labeled descending axons could be seen growing through and at least 500 µm caudal to 
the injury site (Figure 4.3G, H). Despite this, RDA labeling in dorsal column axons got 
progressively weaker towards the injury, and RDA-labeled dorsal column axons were 
never seen in the injury site in any animal (Figure 4.3G, H). 
We were not able to detect tracer-labeled sensory axons wisping into the lesion 
and growing through or beyond the lesion. This could indicate that sensory axons are 
either delayed or not regenerating or that the tracer faded out before the injury site. The 
tracer appears to travel a sufficient distance in four days to label wisping axons because it 
was seen robustly in dorsal column axons all the way up to the injury site in 3 wk 




tracer was not detected in the injury site because of a dilution effect. The most likely 
explanation for why the tracer faded in the dorsal columns of the 6 wk regenerates is 
because the dorsal column axons were degenerating (Stensaas, 1983). Therefore, sensory 
information may not be needed for functional recovery in the newt, or sensory 
information may be transmitted to the brain via a relay circuit that is formed by ascending 
propriospinal axons that do regenerate across the injury site. 
4.3.4 Axons regenerate through white matter  
to reach functional targets 
Axons regenerating beyond the injury site in zebrafish travel preferentially 
through the grey matter rather than white matter to reach functional targets (Becker and 
Becker, 2001).  Our initial study of axon regeneration in whole-mount preparations 
suggested that this is not true in newts (see Figure 4.2K, L). To investigate this further, 
descending axons in three, 6 wk regenerates in the growth beyond the injury site stage 
were analyzed in cross section about 500 µm caudal to the injury site. All axons in all 
three animals traveled in the white matter only (Figure 4.3G). Thus, axons do not re-route 
through the grey matter to reach functional targets in the newt. This suggests that white 
matter inhibitors (Xie and Zheng, 2008) either are not present in the newt spinal cord 
during axon regeneration or that newt axon regrowth is not inhibited by these molecules. 
4.3.5 Extracellular matrix of the injured newt spinal cord 
The ECM associated with an SCI in mammals is inhibitory or repulsive for axon 
growth cone migration (Silver and Miller, 2004). Chondroitin sulfate proteoglycans 




by a variety of cell types including astrocytes and meningeal cells, and they are expressed 
in the glial scar and glia limitans that forms at the border between the injury site and the 
spinal cord. They are also upregulated in the spinal cord itself in a gradient that increases 
as axons approach the injury site (Davies et al., 1999; Tang et al., 2003). ECM proteins 
that are canonically permissive for growth cone migration, such as FN (Bundesen et al., 
2003; Herrmann et al., 2010), laminin (LM) (Busch et al., 2010) and collagen (Col) 
(Hermanns et al., 2001), as well as ECM proteins with more ambiguous effects, such as 
tenascin C (TN-C) (Tang et al., 2003), are also expressed.  Overall, however, the ECM is 
dense and does not support growth cone motility (McKeon et al., 1995; Condic and 
Lemons, 2002). 
Axon regeneration in the newt, then, may be enabled, in part, because the ECM of 
the injured newt spinal cord is not inhibitory. Consistent with previous studies, our initial 
axon regeneration experiments suggest that a dense scar does not form in the lesion (see 
Figure 4.2E-J). To confirm this observation and determine if the ECM in the newt 
contains permissive rather than inhibitory proteins, we used immunohistofluorescence to 
analyze the expression of CSPGs, TN-C, FN, LM, and Col in wisping and spiking stage 
regenerates, the stages in which axons grow across the injury site. Two-and-a-half to 
three wk regenerates were used to target these stages (see Table S4.1), and axons were 
labeled either with the axon tracer or an antibody against neurofilament associated 
protein (3A10).  
In the intact spinal cord, CSPGs are not expressed, though they are expressed in 
the vertebral body in association with chondrocytes (Figure 4.4A). Surprisingly, CSPGs 










Figure 4.4. Wisping axons are associated with loose ECM made up of 
canonically inhibitory and permissive proteins. Axons were labeled with 
3A10 (B-D, G-H, S-T, V) or the axon tracer (F, J-L, N-P, R) and are 
shown in magenta. Each ECM protein is shown in green, and nuclei are 
blue. (A-D) CSPG expression in the intact spinal cord (A, cross section) 
and in wisping stage regenerates (B-D). (B) is a longitudinal section. (C) 
and (D) are cross sections through the terminal vesicle (C), and axons 
wisping into the injury site (D) from the same animal. Schematic 
longitudinal sections of the spinal cord in the upper right corner of (C) and 
(D) show where the section is in relationship to the injury site. Similarly, 
the expression of TN-C (E-H), FN (I-L), Col XII (M-P), LM (Q-T), and 
pigment (U, V) is shown. (W) A section adjacent to the one shown in (B) 
treated with chABC before incubation with the CS-56 antibody. (X) A 
section adjacent to the one shown in (E) treated only with secondary 
antibody; the primary antibody was omitted. D, dorsal; V, ventral; R, 










blood vessels (Figure 4.4B, C) and are expressed near wisping axons (Figure 4.4B, D). 
CSPGs are not found in the grey or white matter of the injured spinal cord and do not 
form a barrier between the cord and injury site. Thus, astrocytes in the spinal cord do not 
appear to express CSPGs. CSPGs also do not form a dense scar within the lesion.  
Unlike CSPGs, TN-C, FN, Col, and LM are expressed in the intact cord in association 
with the meninges and blood vessels (Figure 4.4E, I, M, Q). After injury all of these 
proteins are expressed in a pattern similar to CSPGs. They are associated with the 
meninges and blood vessels (Figure 4.4F, G, J, K, N, O, R, S) and are expressed near 
wisping axons (Figure 4.4F, H, J, L, N, P, R, T). These proteins are not found within the 
grey or white matter of the injured spinal cord, do not form a barrier between the cord 
and injury site, and do not form a dense scar within the injury site. We occasionally 
detected a weak TN-C signal within the white matter of the spinal cord, but this signal 
was not significantly above background noise (autofluorescence and non-specific 
staining). A previous study detected a stronger TN-C signal in the white matter of the 
intact and regenerating newt tail spinal cord (Caubit et al., 1994). We were unable to 
reproduce these results, perhaps because we were analyzing a different region of the 
spinal cord, a different regenerative context, or TN-C expression with different TN-C 
antibodies.  
In summary, similar inhibitory and permissive ECM proteins are expressed in the 
injured newt and mammalian spinal cords, but the pattern of expression is different. In 
the newt, the ECM associated with wisping axons is loose and open, and a dense scar 
does not form. Also, ECM proteins are not present within the grey or white matter of the 




cord and the injury site, though we do have preliminary evidence that such a barrier may 
exist transiently during the wrapping stage (see Figure S4.5). Overall, even though 
inhibitory CSPGs are expressed, the ECM of the injured newt spinal cord does appear to 
be more permissive for axon growth cone migration than that of the injured mammalian 
spinal cord.  
4.3.6 Meningeal and endothelial cells are  
associated with wisping axons 
Given that cells closely associated with axons growing across the injury site and 
cells that create the permissive ECM are likely to be playing an important role in 
enabling axon regeneration, we sought to identify these cells. We hypothesized that they 
may be meningeal and/or endothelial cells because in the intact and regenerating spinal 
cord, ECM proteins appear to be expressed by cells of the meninges and blood vessels, 
not by cells in the grey or white matter (Figure 4.4). Thus, astrocytes and EG in the spinal 
cord do not appear to express ECM, at least not around their cell bodies. Our hypothesis 
is also supported by the fact that in the intact spinal cord, pigmented cells are only found 
in the meninges and blood vessels (Figure 4.4U), and pigmented cells are associated with 
wisping axons (Figure 4.4V). Additionally, many cells associated with wisping axons 
appear to be meningeal cells because they are continuous with the meninges (Figure 4.2). 
The meninges appear to regenerate ahead of regrowing axons, and some regrowing axons 
even appear to follow the regenerating meninges (Figure 4.5D; see also Movie 4.2).  
To determine if cells associated with wisping axons and ECM are endothelial 
cells, we used the endothelial cell marker, von Willebrand Factor (vWF), which appears 










Figure 4.5. Meningeal and endothelial cells are associated with wisping 
axons. (A-D) Axons were labeled with the axon tracer (B, C) or 3A10 (D) 
and are shown in magenta, vWF is green (A-C) and nuclei are blue. (A) 
Cross section through intact spinal cord. (B) Longitudinal section through 
the SCI of a wisping stage regenerate labeled with anti-FN (white, shown 
separately in B’) and anti-vWF (shown separately in B”). Arrowheads, 
cells double-labeled with FN and vWF. (C) Cross section through axons 
wisping into the injury site of a wisping stage regenerate. Schematic 
longitudinal section of the spinal cord in the upper right corner shows 
where the section is in relationship to the injury site. (D) Single confocal 
plane of a longitudinal thick section of a wisping/spiking stage regenerate. 
Arrowhead, meninges (m). (E-I) Longitudinal section through a wisping 
stage regenerate imaged with EM. (E) Region containing axons wisping 
ahead of the TV (TV). Asterisks, phagocytic cells. (F) Enlargement of 
meningeal cells in box F of (E). (G) Enlargement of meningeal-like cell in 
box G of (E) that is associated with dura mater ECM (ecm). Arrowhead, 
closed loop formed by meningeal-like cell processes; arrow, process 
resembling dura mater cell process. (H) Enlargement of meningeal-like 
cell in box H of (E), rotated 90°. This cell’s processes (arrowheads) wrap 
around a bundle of axons (ax) cut in cross section. (I) Enlargement of box 
I in (H) showing that this cell’s processes (arrowheads) are also associated 
with ECM (ecm). D, dorsal; V, ventral; R, rostral; C, caudal. Scale bars: 









regenerates, vWF+ cells can be found in the injury site and near (Figure 4.5B, B”) and 
ahead of (not shown) regenerating axons. These cells are also associated with FN, though 
not all of the FN is associated with vWF+ cells (Figure 4.5B, B’, B”). It has been 
hypothesized that blood vessels and nerves, because of their close proximity and parallel 
tracts, guide each other during development (Larrivee et al., 2009). To determine whether 
they might guide one another during newt spinal cord regeneration, we analyzed injury 
sites in cross sections. We found that although vWF+ cells and axons are in the injury site 
at the same time, they do not need to be in direct contact with each other (Figure 4.5C). 
Therefore, regenerating blood vessels and axons do not appear to guide one another 
across the injury site, at least not through a contact-mediated mechanism.  
Many cells in the injury site were not vWF+, and much of the FN was not 
associated with vWF+ cells. We, therefore, sought to determine, more conclusively, if any 
of the cells closely associated with wisping axons and ECM were meningeal cells. 
Meningeal cell markers such as RALDH2 and NG2 (Mey et al., 2005) did not produce a 
signal in our preparations (see Table S4.2), so we used electron microscopy (EM) to 
analyze cell types based on ultrastructure. In the intact and regenerating spinal cords, 
meningeal cells, in general, have an electron dense cytoplasm filled with mitochondria, 
an elongated nucleus with some clumped chromatin, and thin dark processes that are 
often associated with ECM (Figure 4.5E, F; see also Figure S4.6). None of the other cell 
types in the intact cord shared these characteristics of meningeal cells (see and compare 
Figures S4.6 and S4.7). In regenerating spinal cords, we observed cells with meningeal 
cell characteristics closely associated with regrowing axons. Figure 4.5H shows an 




mitochondria, an elongated nucleus with some clumped chromatin, and thin dark 
processes that appear to wrap around a bundle of axons that has been cut in cross section. 
Processes from this cell are also associated with ECM (Figure 4.5I). Another meningeal-
like cell (Figure 4.5G) was associated with dura mater-like elements, namely ECM and 
fine, dark cell processes (see Figure S4.6B). Processes from the cell in Figure 4.5G form 
a closed loop, which suggests they may be attempting to wrap or cup around structures in 
their environment. Figure 4.6E shows another example of a meningeal-like cell process 
that is closely associated with regenerating axons as well as ECM.   
It is difficult to know with certainty the identity of the meningeal-like cells. 
Stensaas (1983) suggested that cells with these characteristics were dark astrocytes 
derived from EG. Morphologically, however, these cells and their processes resemble 
meningeal cells far more than they do EG and astrocytes (see Figures S4.7 and S4.8). 
Although these cells appear to wrap around axons, we and Stensaas (1983) saw no 
evidence of them forming myelin, and therefore we do not think they are 
oligodendrocytes or Schwann cells. Further support for the idea that these cells may be 
meningeal cells comes from studies of meningeal cells that are transplanted into injured 
mammalian spinal cords along with olfactory ensheathing cells (OECs). Such meningeal 
cells appear to wrap axons into fascicles much like fibroblasts in the perineurium of 
peripheral nerves wrap axons (Li et al., 1998; Lakatos et al., 2003). These meningeal 














Figure 4.6. An inflammatory response is present, but not detrimental to 
axon regeneration. (A) Longitudinal section through a wisping stage 
regenerate. Axons were labeled with 3A10 (magenta), nuclei are in blue, 
and fluorescent channels were laid over the phase image. (B) A section 
adjacent to (A) stained with H&E. Many small cells with dark blue nuclei 
are present near wisping axons. (B’) Enlargement of blue box in (B). 
Lymphocytes (arrowhead) and monocytes (arrows) can be identified near 
wisping axons. (C-E) Longitudinal section through a wisping stage 
regenerate imaged with EM. (C) Region containing axons regenerating 
into the injury site. Many phagocytic cells (asterisks), or macrophages, can 
be identified near regenerating axons. (D) Enlargement of box D in (C). 
Processes from this macrophage (m) are in direct contact with 
regenerating axons (ax). (E) Enlargement of box E in (C). Another 
example of a meningeal cell-like process (p) that is mingled and closely 
associated with regenerating axons (ax). ecm, ECM; R, rostral; C, caudal. 







4.3 7 Ependymoglial and astrocytic processes 
are associated with wisping axons 
As mentioned above, axons are often seen wisping ahead of the central canal, and 
thus, a pre-formed ependymal tube does not appear to be required for axon regeneration 
after an SCI. To determine if EG still might be playing a role in axon regrowth, we used 
an antibody against glial fibrillary acid protein (GFAP). In the intact newt spinal cord, 
GFAP weakly labels EG cell bodies, strongly labels astrocytic cell bodies and strongly 
labels radial processes from both these cell types (Figure 4.7A). Therefore, this cell 
marker enabled us to observe the astrocytic as well as EG response.  
In the injured spinal cord, GFAP expression is maintained in astrocytes and EG 
around the central canal. It does not appear to be upregulated, and GFAP+ processes do 
not appear to be thicker than they are in the intact cord (compare Figure 4.7A and B). 
Therefore, astrocytes do not appear to become hypertrophic. In the injury site, only a few 
GFAP+ cell bodies can be found (Figure 4.7D, D’). These cells are more likely to be EG 
than astrocytes because they express GFAP only weakly. Thus, astrocytes do not migrate 
into the lesion. In wisping stage regenerates, GFAP+ processes are closely associated with 
wisping axons (Figure 4.7D, D’). These processes likely originate from EG and 
astrocytes that surround the central canal. Rather than being aligned perpendicular to 
axons, as they are during tail regeneration however, the GFAP+ processes are aligned 
more parallel to the direction in which axons travel. This is especially evident in later-
stage regenerates (Figure 4.7E). Note also that the GFAP+ processes do not form a glia 













Figure 4.7. Glial processes are associated with wisping axons and do not 
form inhibitory barriers. Axons were labeled with 3A10 (B, D) or the axon 
tracer (E) and are shown in magenta. Glia were labeled with anti-GFAP 
(green), and nuclei are blue (A-D). (A) Cross section through intact spinal 
cord. GFAP labels EG and astrocytes and all of their processes. (B) 
Longitudinal section through the SCI of a wisping stage regenerate. 
Astrocytes do not become hypertrophic (compare with A). (C) Section 
adjacent to (B) treated only with secondary antibodies, primary antibodies 
were omitted. (D) Longitudinal section through the SCI of a wisping stage 
regenerate. (D’) Enlargement of dotted box in (D). GFAP+ processes 
(arrows) are associated with wisping axons and do not form a glia 
limitans. Only a few weakly GFAP+ cells (arrowhead) are in the injury 
site. (E) Single confocal plane of a longitudinal thick section of a growth 
beyond stage regenerate. GFAP+ processes run parallel to axons across the 
injury site. D, dorsal; V, ventral; R, rostral; C, caudal. Scale bars: 200 µm 









These data demonstrate that, while the EG response after SCI appears to be 
different than that after tail amputation, EG are still likely to be playing an important role 
in enabling axon regeneration, because GFAP+ processes are closely associated with 
axons growing across the injury site. Also, while EG do not appear to migrate into the 
injury site in large numbers, there are a few that appear to do so. 
Furthermore, the astrocytic response in the newt is very much different than that 
seen in mammals. Newt astrocytes do not appear to become hypertrophic, migrate into 
the injury site, express ECM, or form a glial limitans or scar. Instead of inhibiting axon 
regeneration as they do in mammals, newt astrocytes may, like EG, play a supportive role 
because many of the GFAP+ processes associated with axons likely arise from astrocytes 
as well as EG. 
4.3.8 An inflammatory response is present but does not  
appear to be detrimental to regeneration 
It has been hypothesized that inflammation leads to scarring and nonregenerative 
wound healing and that it is not present in systems that regenerate (Harty et al., 2003).  In 
support of this, macrophages in the injured mammalian spinal cord contribute to the 
formation of the scar (Fitch et al., 1999) and have even been shown to physically interact 
with axons to cause retraction (Horn et al., 2008).   
To determine if an inflammatory response might be present in the newt SCI, we 
used hematoxylin and eosin (H&E) staining. With H&E staining, an inflammatory 
response is characterized by the appearance of many small round cells that have dark blue 
nuclei and very little cytoplasm. Lymphocytes have almost no cytoplasm, whereas 




inflammatory response does appear to be present in wisping stage regenerates (n=5, 
Figure 4.6A, B, B’). Figure 4.6B’ highlights some of the more obvious examples of 
lymphocytes and monocytes that are present at this stage. These types of cells are 
associated with the fibrin clot that forms in the injury site and can be identified as early as 
one week after injury (see Figure S4.9A, B-B”).  
To confirm the presence of various types of inflammatory cells, we again tried 
several cell-type specific antibodies, but these did not produce a reliable signal in our 
preparations (see Table S4.2). We were, however, able to identify many phagocytic cells, 
or functional macrophages, in the region of regenerating axons in our EM images. 
Asterisks in Figures 4.5E and 4.6C mark obvious macrophages. These macrophages 
could even be seen to be in direct contact with axons (Figure 4.6D).  
These data demonstrate that an inflammatory response does appear to be present 
in the injured newt spinal cord, but does not appear to be detrimental to the regenerative 
response. In fact, one of the most severe cases of inflammation was seen in a contact 
stage regenerate (see Figure S4.9C, C’). The inflammation, which was likely present at 
earlier stages as well, did not prevent regeneration from progressing to this advanced 
stage. The interaction of newt macrophages with axons, if it also causes axon retraction in 
newts, does not prevent the net response to be that of axon growth. Perhaps the beneficial 
effects the immune system can have on regeneration (Donnelly and Popovich, 2008) 
outweigh any detrimental effects in the newt.   
4.4 Conclusions 
Axons appear to be able to regenerate after an SCI in the newt, in part, because 




scar and interacting to form a glia limitans and as they do in mammals (Shearer and 
Fawcett, 2001; Bundesen et al., 2003; Silver and Miller, 2004), newt meningeal cells and 
glia appear to create a permissive environment for axon regeneration. Figure 4.8 
summarizes the stages of axon regeneration and the roles these cell types play. After an 
SCI, axons initially retract from the end of the cut cord and appear dystrophic, but then 
initiate growth by about 1 wk. Axons wrap around the end of the TV before growing into 
the lesion, perhaps because meningeal cells create a transient basal lamina. Meningeal 
and endothelial cells lead the way across the lesion and are associated with a loose 
extracellular matrix that permits growth cone migration. Axons grow into the injury site 
next and are closely associated with meningeal cells and glial processes that extend from 
EG and astrocytic cell bodies surrounding the central canal. Later in the process, 
ependymal tubes lined with glia extend into the lesion as well. Then, as a unit, meningeal 
cells, axons, and glia close the gap in the spinal cord. Finally, axons enter the cord on the 
opposite side of the injury and travel through white matter to reach functional targets. We 
also noted that although ascending axons do regenerate, sensory axons do not appear to 
be among them and that, overall, this regenerative process can occur in the presence of an 
inflammatory response. 
4.4.1 Model 
Based on our observations, we propose a glia – meningeal cell interaction model 
of spinal cord regeneration: spinal cord regeneration is enabled when meningeal cells and 
glia (astrocytes and EG) interact to form a conduit for axon regeneration rather than an 
inhibitory barrier (scar, glia limitans, and dense ECM). Simpson (1983) hypothesized that 















Figure 4.8. Cellular model of newt axon regeneration. Schematics of 
longitudinal sections through the spinal cord are shown. See text for 








cells and the ependymal epithelium that stimulates the ependyma to proliferate and form 
a scaffold, which guides axons across the lesion. Since astrocytes also appear to be an 
important component in this interaction, we have included astrocytes with the ependymal 
cells and refer to them as glia. Simpson postulated that blastemal cells are the important 
mesenchymal cell after tail amputation, but was not specific about which cells play that 
role after SCI. We suggest that meningeal cells are an important mesenchymal cell after 
SCI and that they, too, can provide a scaffold for axon growth and guidance. 
4.4.2 Glia 
Our model of spinal cord regeneration after an SCI is similar to that after tail 
amputation in that EG play a central role. Their processes are closely associated with 
regenerating axons and may provide a substratum for growth cone migration and 
guidance via cell-cell adhesion. Our data also suggest that astrocytes may play a similar 
role. These astrocytes may be immediate descendants of EG and not the fully mature 
astrocytes seen in the mammalian spinal cord (Schonbach, 1969), and this may explain, 
in part, why they respond so differently to SCI.  The arrangement of the glial processes, 
however, is different from the tail regeneration model, at least initially. Instead of 
extending radially from a pre-formed ependymal tube to form channels through which 
axons can grow (Singer et al., 1979), they extend longitudinally ahead of the TV and run 
roughly parallel to the regenerating axons.  Such glial support may allow the axons to 
grow into the injury site in the absence of a pre-formed tube. They may also help guide 
the EG lining the central canal, and thus the ependymal tube, into the region of wisping 
axons similar to the way in which radial processes guide newborn neurons to their proper 




they may migrate along the processes of other EG (Ghashghaei et al., 2007). Given that 
very few cells in the injury site express GFAP, we do not think many EG undergo an 
epithelial to mesenchymal transition to migrate freely into the lesion as proposed for 
axolotls after SCI (O'Hara et al., 1992). This does not rule out the possibility, however, 
that undifferentiated progeny of EG might migrate into the injury site. Alternatively, 
given that the mesenchymal cells in the axolotl injury site were also GFAP- and were 
associated with FN, such cells could be meningeal and/or endothelial cells. 
4.4.3 Meningeal cells 
Unlike most previous models of salamander spinal cord regeneration, our model 
assigns an important role to meningeal cells. Although they are thought to be detrimental 
to axon regeneration in the injured mammalian spinal cord, meningeal cells are able to 
stimulate, support, and guide developmental and regenerative processes in other contexts. 
Meningeal cells are fibroblast-like, and fibroblasts in flesh wounds are responsible for 
remodeling the ECM into either scar or normal tissue. The difference appears to depend 
on whether the fibroblasts are stimulated by TGFβ1 or TGFβ3 (Ferguson and O'Kane, 
2004). As mentioned previously, meningeal cells harvested from the olfactory bulb, a 
part of the nervous system that does regenerate, and transplanted into a mammalian SCI 
along with OECs appear to fasciculate axons into perineurial-like structures and enhance 
the ability of OECs to remyelinate axons (Li et al., 1998; Lakatos et al., 2003). During 
development, the meninges serve as substratum for and secrete a chemoattractant, 
CXCL12, which regulates the migration of Cajal-Retzius cells (Borrell and Marin, 2006). 
In the developing forebrain, the meninges secrete retinoic acid (RA) which stimulates 




mammalian SCI express RA and permissive ECM proteins such as LM and FN (Shearer 
et al., 2003; Mey et al., 2005). RA has been shown to stimulate and possibly be an 
attractant for neurite outgrowth (Clagett-Dame et al., 2006; Wang and Scott, 2008). 
While the permissive ECM proteins expressed by meningeal cells in vitro tend to form a 
basal lamina that axons cannot cross, axons appear to grow quite well along it (Shearer et 
al., 2003). Thus, the basal lamina can either guide or inhibit axon regeneration depending 
on its orientation. In fact, following a large ablation of the spinal cord in which the 
meninges were left intact, axons were seen regenerating along the basal lamina of the 
meninges, which was oriented in a productive direction parallel to axon regrowth 
(Stensaas, 1983).  
4.4.4 Axons 
Our model does not exclude the possibility that axons and axon-intrinsic 
properties also play an important role in newt spinal cord regeneration. The 1 wk required 
for growth initiation suggests that an intrinsic growth potential is activated. This is 
supported by the fact that a one week conditioning lesion encouraged neurite outgrowth 
from newt retinal explants (Becker et al., 1999). Activation of intrinsic growth could also 
enable axons to overcome any inhibition CSPGs might inflict, similar to the way in 
which embryonic neurons adapt to CSPGs (Condic et al., 1999; Lemons et al., 2005). 
Furthermore, matrix metalloproteinases are upregulated during newt spinal cord 
regeneration (unpublished observations), and if they are expressed in growth cones, they 
could break down inhibitory ECM molecules and allow the axons to grow through 
regions that would normally be nonpermissive. Axons may also directly influence the 




regeneration, and they stimulate Schwann cells to produce anterior gradient protein (AG), 
a factor that is sufficient to rescue regeneration in de-nervated limbs (Kumar et al., 2007). 
Regenerating optic nerve axons in the frog appear to stimulate a breakdown of the blood 
brain barrier at the front of regenerating axons (Tennant and Beazley, 1992). Finally, 
when degenerated optic nerve fragments containing hypertrophic astrocytes are 
implanted into an optic nerve injury site in frogs, axons grow into the grafted tissue and 
appear to stimulate the reactive astrocytes to adopt a more permissive architecture: the 
astrocytes extend radial processes and form compartments for axon elongation (Reier et 
al., 1983). Thus, newt axons may play a role in stimulating appropriate glial and 
meningeal cell responses. 
4.4.5 Summary 
If meningeal cells and glia support the development and regeneration of the 
nervous system in some contexts, why do they not do so in all contexts? Although no 
definitive answer can be put forward, we suspect that the state of differentiation of the 
cells may play a key role. In the newt spinal cord, EG maintain characteristics of radial 
glia of the developing cortex (Ferretti et al., 2003), astrocytes may be recent progeny of 
EG (Schonbach, 1969), and many differentiated cells have the ability to dedifferentiate 
and become more progenitor-like (Odelberg, 2005). Learning more about how newt cell 
types are intrinsically different and what factors stimulate their behavior will undoubtedly 
give us new insights into how to improve spinal cord regeneration in mammals. 
Identifying effective treatments for spinal cord injury in mammals has been so intractable 
that it is imperative we take full advantage of the opportunity to learn how nature has 






Adult newts, Notophthalmus viridescens, were purchased from Charles D. 
Sullivan Co. Inc., (Nashville, TN), housed at 22°C in glass aquariums equipped with 
water filters, and fed live blackworms, Lumbriculus varietgatus (Eastern Aquatics, PA). 
All animal protocols were approved by the University of Utah Institutional Animal Care 
and Use Committee. 
4.5.2 Spinal cord injury 
Newts were anesthetized by submersion in 0.1% Tricaine (Ethyl 3-aminobenzoate 
methanesulfonate salt, Sigma, A5040) in 20 mM Tris-HCl, pH 7.5 for 10 min and placed 
in ice for 30 min prior to surgery. Complete transection injuries were performed similar 
to those described in Davis et al (1989; 1990). After swabbing the skin with 10% 
Providone Iodine, a deep incision was made between vertebral bones about 1 cm rostral 
to the hindlimbs. Using forceps, the vertebrae were gently and slightly separated and the 
dorsal lamina of the caudal vertebra was removed to expose the spinal cord. The spinal 
cord was cut completely with fine spring scissors. Blood was irrigated with sterile 85% 
phosphate buffered saline (PBS) when necessary. Animals were kept moist during the 
procedure, placed on ice for 15 min after the surgery, and allowed to recover in bins that 
were tilted to produce a shallow area of water. Bins were cleaned and filled with fresh de-






4.5.3 Axon tracer application 
Our procedure was modified from that used in zebrafish (Becker et al., 1997; 
Becker and Becker, 2001). Three axon tracers were tried: BDA (3kD, lysine fixable, 
Invitrogen, D7135), RDA (3kD, lysine fixable, Invitrogen, D3308), and biocytin (Pierce, 
28022). RDA appeared to work as well as BDA, but was only used when two tracers 
were needed in the same animal. Biocytin, which was reported to reveal thin processes 
better than a 10 kD RDA (Becker et al., 1997), unfortunately did not produce a signal in 
our preparations, perhaps because of the decalcification step in tissue processing (see 
below). BDA and RDA were prepared similarly: small pieces of gel foam (Pharmacia & 
Upjohn Co., MI) were soaked in 1.5 µl of a 10% solution and allowed to air dry 40 min 
in a tissue culture hood to further concentrate the solution. Fast green dye (Fisher, F-99) 
was added to the BDA solution at 0.05 mg/ml to make it visible in vivo. Biocytin did not 
readily go into solution at 10%, but a slurry was made. Small pieces of gel foam were 
soaked in 10 µl of the slurry, air dried completely, and stored at -20°C. To apply tracer to 
the spinal cord, the cord was transected one vertebral segment (about 2 mm) rostral or 
caudal to the original injury site using the same procedure described above and a piece of 
gel foam saturated with tracer was inserted into the gap. To apply tracer to the sciatic 
nerve, an incision was made along the course of the sciatic blood vessel on the posterior 
aspect of the hindlimb where the hindlimb joins with the body. Fine forceps were used to 
tease the nerve from the vessel, and the nerve was transected with fine spring scissors. A 
piece of gel foam saturated with tracer was applied and the wound was sealed closed with 
Vetbond tissue adhesive (3M). Excessive bleeding was controlled before tracer 




the animal to sit on ice for several minutes. Use of this technique was minimized, 
however, because it decreased the efficiency of tracer uptake. 
4.5.4 Tissue harvest, fixation, and decalcification 
Animals were anesthetized as above, placed on ice for at least 15 min, then 
perfused with about 1.5 ml 85% PBS followed by 3 ml periodate-lysine-
paraformaldehyde (PFA) fixative (PLP: 75 mM lysine, 10 mM sodium periodate, 0.5% 
PFA in 85% PBS, pH 7.4; 0.1 M lysine and 2% PFA stocks were stored at -20°C and 
ingredients were mixed and used within 2 hours) (McLean and Nakane, 1974). All 
incubations were performed rocking at room temperature (RT) and rinses were for 20-30 
min, three times, unless otherwise specified. The spinal column was harvested in about 4 
mm long segments, post-fixed in PLP for 2 hours, rinsed with PBS (137 mM NaCl, 2.7 
mM KCl, 8.1 mM Na2HPO4, 1.15 mM KH2PO4, pH 7.4), rinsed in fresh PBS overnight 
at 4°C, decalcified with Morse’s solution (22.5% formic acid, 10% sodium citrate) for 24 
hours, and rinsed with PBS. Some of the spinal cords prepared for paraffin sections were 
not perfusion fixed and this did not seem to affect the results, though perfusion did make 
tissue prepared for thick and frozen sections easier to section. An alternative fixative, 4% 
PFA, was tried, but the quality of sections was not improved, there was more 
autofluorescence, and some antibodies did not work as well. 
4.5.5 Thick sections and fluorescent labeling  
(spinal cord whole-mounts) 
Methods were adapted from previous studies (Klymkowsky and Hanken, 1991; 




rocking at RT unless otherwise specified. Decalcified tissue was bleached with 
formamide bleach (6% hydrogen peroxide, 3% formamide, 0.1% Triton X-100 in PBS) 
for about 2 hours; rinsed with PBS for 20-30 min, three times; and embedded in 4% 
agarose. Longitudinal sections containing the whole spinal cord (about 350 µm thick) 
were cut on a vibratome and collected in ice cold PBS. Sections were transferred to 0.67 
ml centrifuge tubes, permeabilized with PBS-TxD (PBS containing 0.5-2% Triton X-100 
and 20% DMSO; 0.5% Triton X-100 was sufficient for streptavidin, 2% was necessary 
for antibodies) overnight and incubated in streptavidin or primary antibody diluted in 
PBS-TxDB (PBS-TxD containing 1% BSA (EMD, 2960) and 0.1% fish skin gelatin 
(Sigma, G7765) as blocking reagents) for 7 days for streptavidin or 10 days for antibody 
penetration. Sections needing incubation with secondary antibodies were rinsed with 
PBS-Tx (PBS with 2% Triton X-100) for 30 min, five times and incubated in secondary 
antibody diluted in PBS-TxDB for 10 days. Sections were then rinsed in PBS for 30 min, 
four times; rinsed in TNT (100 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.05% Tween-20) 
for 30 min; incubated in SYTOX green (Invitrogen, S7020) diluted 1/1000 in DMSO, 
then 1/25 in TNT for 3 hours to stain nuclei; and rinsed in TN (TNT without Tween-20) 
for 10 min, three times. Sections were transferred to glass vials, dehydrated through a 
methanol (MeOH)/TN series (20%, 50%, 75%, 100% MeOH; 15 min each); and cleared 
in BABB (1 part benzyl alcohol, 2 parts benzyl benzoate) overnight at 4°C (not rocking).  
4.5.6 Frozen sections 
Frozen sections of the injured spinal cord were difficult to obtain presumably 




contains tissues of heterogeneous density: the muscle and bone are rigid and dense, while 
the spinal cord is quite soft. Therefore, methods were adapted from Tokuyasu (1989). 
Perfusion-fixed, decalcified tissue was cryoprotected to 2.3 M sucrose in PBS (3 hours in 
25%, 3 hours in 50%, overnight in 75%, 24 hours in 100% 2.3 M sucrose; rocking and at 
RT) and frozen quickly in OCT (Ted Pella, 27050) with liquid nitrogen to minimize 
freezing artifacts. Sections 16 – 20 µm thick were obtained on a cryostat with the 
chamber temperature set to -35°C and the object temperature set to -34°C. For intact 
spinal cord, variables could be somewhat relaxed. Tissue could be cryoprotected to 1.6 M 
sucrose and perfusion was not critical. Sections were stored at -20°C and, prior to 
fluorescent labeling, thawed, baked onto the slides for 1 hour at 50°C, and rinsed in PBS 
for 5 min.  
4.5.7 Paraffin sections 
All incubations were performed with rocking at RT. Decalcified tissue was 
dehydrated with ethanol (EtOH, 50% for 30 min, 70% for 30 min, 95% for 30 min, 100% 
for 30 min, 100% for 1 hour), infiltrated (75% Hemo-De in EtOH for 20 min, 100% 
Hemo-De for 1 hour, paraffin for 1 hour at 60°C and 15 Hg vacuum), and embedded in 
paraffin. Sections 10 – 20 µm thick were mounted onto slides, left on a 37°C slide 
warmer overnight, and stored at 4°C. Prior to fluorescent labeling or staining, sections 
were dewaxed (Hemo-De for 10 min, two times; 75% Hemo-De in EtOH for 5 min; 
100% EtOH briefly and then for 3 min) and rehydrated (95% EtOH for 3 min, 70% EtOH 
for 3 min, PBS or water for 5 min; PBS was used for fluorescent labeling and water was 





4.5.8 H&E staining 
Paraffin sections rehydrated in water were stained: hematoxylin (Harris modified, 
with acetic acid, Fisher SH26-500D) 4 min, running tap water 5 min, 70% EtOH briefly, 
acidified 70% EtOH (10 drops of concentrated HCl to 200 ml 70% EtOH) 1.5 min, 
bluing solution (10 drops of NH4OH in 200 ml EtOH) 1 min, Scott’s solution (1 g sodium 
bicarbonate, 10 g magnesium sulfate in 500 ml water) 3 min, running tap water 5 min, 
70% EtOH briefly, 0.1% Eosin in 95% EtOH (made from 0.5% Eosin Y Solution, Sigma 
HT110-1-32) 1 min, 95% EtOH briefly, 100% EtOH 5 min, 75% Hemo-De in EtOH 5 
min, 100% Hemo-De 5 min. Coverslips were mounted with Cytoseal 60 (Fisher, 23-244-
256).  
4.5.9 Fluorescent labeling in paraffin or frozen sections 
Sections were blocked in PBS-TxB (PBS with 0.2% Triton X-100, 1% BSA and 
0.1% fish skin gelatin) for 1 hour; incubated with primary antibody diluted in PBS-Tx 
(PBS with 0.2% Triton X-100) overnight at RT; rinsed with PBS for 10 min, three times; 
incubated with secondary antibody or streptavidin diluted in PBS-Tx for 4 hours; rinsed 
with PBS for 10 min, two times; rinsed with TNT or TN for 10 min; incubated with 
SYTOX green (Invitrogen, S7020) diluted 1/1000 in DMSO, then 1/50 in TNT or 
Hoechst 33342 (Invitrogen, A10027) diluted 1/2000 in TNT for 30 min to stain nuclei; 
rinsed in TN for 10 min, 50% TN for 10 min, and water for 10 min. Coverslips were 
mounted with Fluoromount G (Fisher, OB100-01) and sealed with clear nail polish. For 
some experiments on paraffin sections, incubation with primary antibody was extended to 




chondroitinase ABC (chABC) were treated before the blocking step. They were 
equilibrated in tris acetate buffer (50 mM Tris-HCl, pH 8.5, 60 mM Sodium Acetate, 
0.02% BSA, 0.5% Triton X-100; made fresh, pH 8.0) for 5 min, treated with chABC 
solution (7.5 U/ml chABC stock diluted 1:50 in tris acetate buffer; stock was chABC, 
Sigma C2905, EC 4.2.2.4, reconstituted in 0.01% BSA) for 1 hour at 37°C, and rinsed 
with PBS for 5 min, three times.  
4.5.10 Antibodies and Streptavidins 
Primary antibodies and dilutions used are listed in Table 4.2. Additional primary 
antibodies that were tried are listed in Table S4.2. Secondary antibodies (Invitrogen, 
whole antibodies, 2 mg/ml, conjugated to Alexa 488, 568, 594, or 633) were diluted 
1/100. Streptavidin-Cy5 (Invitrogen, SA1011) and Streptavidin-Alexa 633 (Invitrogen, 
S21375) were diluted to 4 µg/ml. The FN and Col XII antibodies and one TN-C antibody 
are newt-specific and have been characterized (Onda et al., 1990; Nace and Tassava, 
1995; Wei et al., 1995). The non-newt-specific antibodies appear to be specific in that 
they produced appropriate expression patterns and are specific in western blots (not 
shown, not done for vWF and CSPG antibodies). The specificity of the CSPG antibody 
was verified by treating adjacent sections with chABC and incubating them with the 
CSPG antibody. The specificity of the secondary antibodies was verified by treating 
adjacent sections with secondary antibodies in the absence of primary antibodies. Very 
little non-specific signal was seen in either case (see Figure 4.4W, X), and what little was 
seen tended to appear in the white matter. The chick-specific TN-C antibody produced an 










Table 4.2. Table of antibodies 
Antigen Antibody Type Company, Cat # Dilution, Format 
CSPGs (chick) mouse IgM mAb Sigma, C8035 (CS-56) 1/100, ascites 
Tenascin-C (chick) rabbit pAb Chemicon, AB19013 1/100, concentrate 
Tenascin-C (newt) mouse IgM mAb DSHB, MT1 1/25, concentrate 
Fibronectin (newt) mouse IgG mAb DSHB, MT4 1/50, concentrate 
Collagen XII (newt) mouse IgG1 mAb DSHB, MT2 1/50, concentrate 
Laminin (mouse) rabbit pAb Sigma, L9393 1/25, concentrate 
Fibrin (human) mouse IgG1 mAb ADI, 350 1/50, concentrate 
Neurofilament associated 
protein (chick) 
mouse IgG1 mAb DSHB, 3A10 1/50, supernatant 
GFAP (cow) rabbit pAb Dako, Z0334 1/200, concentrate 
von Willebrand Factor 
(human) 




and so it was used instead. The antibody against Col XII was used to approximate the 
expression of Col I since it is found in association with Col I and may enhance the 
stability of the ECM by bridging collagen fibrils (Reichenberger et al., 2000; Bader et al., 
2009). Since paraffin processing may affect CS-56 labeling, CSPGs were analyzed in 
frozen sections. TN-C, FN, LM, and Col were analyzed in paraffin and frozen sections. 
Expression patterns were also verified in whole-mount preparations (not shown).  
4.5.11Confocal imaging and image processing 
Sections labeled with fluorescent dyes were imaged on an Olympus FV300 or 
FV1000 laser scanning confocal microscope using a 10X or 20X air objective. Images 
were processed with ImageJ, version 1.40g (W. Rasband; http://rsb.info.nih.gov/ij; NIH, 
Bethesda, MD) and Adobe Photoshop CS2. Levels were adjusted in Photoshop to 
maximize the signal to noise ratio but the same adjustments were made to experimental 
and control images.  
4.5.12 Preparation of tissue for EM 
Methods were adapted from Anderson et al (2009). Animals were anesthetized as 
above, then perfused with about 1.5 ml 85% PBS followed by 3 ml EM fixative (2.5% 
glutaraldehyde, 1% formaldehyde, 3% sucrose, 1 mM MgSO4 in 0.1 M cacodylate buffer 
(CB), pH 7.4). The spinal column was harvested in about 4 mm long segments; post-
fixed in EM fixative overnight at RT; decalcified in cold EDTA solution (0.1 M EDTA, 
pH 7.2-7.4 with 4% glutaraldehyde) for 4 days at 4°C; rinsed in 0.1 M CB for 20 min, 3 
times; rinsed in PBS briefly; and embedded in 4% agarose. Longitudinal sections 




collected in ice cold PBS. Sections were returned to 0.1 M CB; osmicated (1% OsO4 in 
0.1 M CB) for 1 hour; rinsed in 0.1 M CB for 10 min, 3 times; partially dehydrated (50%, 
75% MeOH; 10 min each); treated with 1% uranyl acetate in 75% MeOH for 1 hour; 
fully dehydrated (75%, 85%, 95%, 100%, 100% MeOH; 10 min each); infiltrated with 
resin (100% acetone 10 min, 2 times; 75% resin in acetone overnight; 100% resin 1 
hour); embedded in epoxy resin [2 parts dodecenyl succinic anhydride (DDSA, Ted Pella, 
18022), 1 part eponate 12 resin (Ted Pella, 18005), 0.06 parts DMP30 accelerator (Ted 
Pella, 18042)] and cured at 60°C for 2 days. Sections were re-embedded for longitudinal 
sectioning, and 80 nm sections were collected onto carbon-coated Formvar films in gold, 
single-hole grids, stained with 5% uranyl acetate for 1 hour and 1% lead citrate for 25 
min, and imaged at 80 KeV in a JEOL JEM 1400 electron microscope at 5,000X 
magnification. Images were captured digitally on a GATAN Ultrascan 4000 16 
megapixel 16-bit camera and mosaicked with ir-tools (Anderson et al., 2009). Mosaics 





























Figure S4.1. The largest spinal nerves are associated with the S1 and T-1 
vertebrae. (A) Close-up view of S1, dorsal aspect. The rib associated with 
this vertebra articulates with the ilium of the pelvis to form the SI joint. 
(B) Ventral side of spinal column showing vertebrae T-4 to S2/C1. The 
largest spinal nerves (arrowheads) are associated with T-1 and S1. T-2 is 
intermediate in size. T-4, T-3 and S2/C1 are small. Dotted circles, 
approximate location of the spinal ganglia; dotted lines, approximate 
course spinal nerves take to spinal ganglia. Note that the actual location of 
the SCI in this animal is 1 segment rostral (between T-5 and T-4) to the 
targeted site (between T-4 and T-3). (C) Close-up of T-1 and S1 shown in 
(B). More flesh has been removed to demonstrate that the vertebra 
associated with the caudal-most large spinal nerve is indeed S1. The rib 






















Figure S4.2. Retraction and growth initiation stage images seen in z-
projections. The difference between the retraction and growth initiation 
stages is apparent throughout the whole spinal cord and is not just a 
function of which z-plane was chosen for presentation. (A-D) Images of 
retraction (A, B) and growth initiation (C, D) shown in Figure 4.2. All are 
single confocal planes, except (B), which is a z-projection of 4 planes. 
(A’-D’) Z-projections of all planes through the spinal cord, showing just 
the axon tracer channel, for the same animals in (A-D). In the retraction 
stage, fewer axons extend to the end of the cut cord (arrowheads). R, 






















Figure S4.3. Size of gap in spinal cord at each stage. Gap size increases 
before it decreases and is largest during the wrapping stage. dark lines, 
median; box, interquartile range (IQR, 25% - 75%); whiskers, most 
extreme data point that is no more than 1.5 IQT from the box; small circle, 
outlier. The size of the gap during the wrapping stage is statistically 
different (asterisk) from that during the retraction stage, with p < 0.001 









Figure S4.4. Sloppiness and misalignments in axon regeneration. Axon 
regeneration has some tolerance for sloppiness, but gross misalignments 
may result in a delay or failure to recover. All images are montages of 
single confocal planes of longitudinal thick sections, except (F) which is a 
cross section. Axons in all images were labeled with the axon tracer 
(magenta), and nuclei are green. (A, A’, A”) A 9 wk regenerate in the 
growth beyond stage that had recovered swimming function. Gross 
misalignments are not present. The ependymal tubes have connected to re-
establish a continuous central canal (A), yet axon regeneration appears to 
be a little sloppy in that some axons appear to decussate (arrowhead in A’) 
and wrapping axons are still evident (open arrowhead in A”); however, 
this has not interfered with functional recovery. (B) A 4 wk regenerate in 
the growth beyond stage that had not recovered function. Similar to (A), 
axons appear to wrap (open arrowhead) and decussate (arrowhead). This 
animal may not have recovered yet because it was sacrificed at such an 
early time point. (C) A 9 wk regenerate in the growth beyond stage that 
had not recovered function. A long spike appears to have elongated from 
the caudal side (dotted lines), and this may indicate that the gap in the cord 
was large. Recovery, therefore, may be delayed. (D) A 6 wk regenerate in 
the spiking stage that had not recovered function. The whole spike appears 
to be veering off in the wrong direction and does not line up properly with 
the cord on the other side (dotted lines). This gross misalignment may 
have prevented this animal from ever recovering function. Note that the 
whole spike, made up of meningeal cells, axons, and EG, is moving as 
unit in the wrong direction. Arrow, dorsal root to the spinal ganglia. (E) A 
9 wk regenerate in the growth beyond stage that had not recovered 
function. Two ependymal tubes (fat arrows) appear to have formed on the 
rostral side. The more prominent one is misaligned, and the less prominent 
one is properly aligned. Thus, the less prominent one may be forming to 
correct the misalignment. Recovery may be delayed as a result. (F) Cross 
section through a 9 wk regenerate in the growth beyond stage that had not 
recovered function. Axon regeneration appears to be sloppy in that axons 
are wisping dorsally towards the tissue wound that was created to gain 
access to the spinal cord. Recovery may be delayed as a result. R, rostral; 
C, caudal; D, dorsal; V, ventral. Scale bars: 500 µm (A-E, same scale); 

























Figure S4.5. A glia limitans-like structure may be present during the 
wrapping stage. Longitudinal sections through wrapping stage regenerates. 
Axons were labeled with the axon tracer in (C) and (D) and are shown in 
magenta. Each ECM protein is shown in green, and nuclei are blue. Col 
XII (A), FN (B), and TN-C (C) expression wraps around the end of the 
cord, while LM (D) expression does not. R, rostral; C, caudal. Scale bar: 


















Figure S4.6. Meninges of the intact spinal cord. Longitudinal section 
through the intact spinal cord imaged with EM. (A) Region containing the 
meninges. p, pia mater; a, arachnoid mater; d, dura mater; sas, 
subarachnoid space; ecm, ECM; ef, glial end feet; o, oligodendrocyte. (B) 
Enlargement of box B in (A) showing skinny, dark processes of dura 
mater cells (arrows) associated with collagen fibrils (c) of the dura mater. 
(C) Enlargement of box C in (A) showing layers of arachnoid cell 
processes (a), a skinny process from a dura mater cell (arrow), and 
collagen (c). (D) Enlargement of box D in (A) showing a pia mater cell. 
(E) Enlargement of box E in (A) showing neural collagen (nc). (F) 
Enlargement of box F in (A) showing the basement membrane 
(arrowhead) at the glia limitans of the spinal cord, collagen (c) and neural 
collagen (nc). R, rostral; C, caudal. Scale bars: 15 µm (A), 3 µm (D), 1.5 






















Figure S4.7. Other cell types in the intact spinal cord. Longitudinal 
section through the intact spinal cord imaged with EM. (A) Region 
containing the central canal (cc), EG layer (EG) and a portion of the grey 
mater (gm). (B) Enlargement of box B in (A) showing astrocytes. (C) 
Enlargement of box C in (A) showing the cytoplasm of light EG. (D) 
Enlargement of box D in (A) showing the cytoplasm of dark EG. (E) A 
microglial cell. (F) An oligodendrocyte. R, rostral; C, caudal. Scale bars: 
























Figure S4.8. Glia of the regenerating spinal cord. (A-D) Longitudinal 
section through a wisping stage regenerate imaged with EM. (A) Region 
containing axons wisping ahead of the TV (TV). (B) Enlargement of box 
B in (A) showing a light glial process (EGL) that is associated with 
regenerating axons (ax). (C) Enlargement of box C in (A) showing light 
(EGL) and dark (EGD) EG lining the TV (TV). (D) Enlargement of box D 
in (A) showing a dark EG process (EGD) associated with axons (ax). R, 




















Figure S4.9. The inflammatory response in early and late stage 
regenerates. (A, B) Adjacent longitudinal sections through a 1 wk 
regenerate labeled with an anti-fibrin antibody (A) and stained with H&E 
(B). A fibrin clot is formed in the injury site (A), and inflammatory cells 
can already be identified in this clot (B). (B’, B”) Enlargement of primed 
and double primed boxes in (B). Lymphocytes (arrowheads in B’) and 
monocytes (arrow in B”) can be identified. Asterisk, fibrin clot. (C) 
Longitudinal section through a contact stage regenerate. A relatively 
strong inflammatory response has not prevented this animal from 
progressing to this late stage. (C’) Enlargement of box in (C). 
Lymphocytes (arrowhead) and monocytes (arrows) can be identified. R, 
rostral; C, caudal. Scale bars: 200 µm (A; B, C, same scale), 50 µm (B’, 
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Table S4.1. Stages of 2.5 to 3 wk regenerates analyzed after initial study. 
Exp-Animal Prep Antibody/ Stain Axon Label 
Stage on  
Rostral Side* 
Stage on  
Caudal Side* 
3wk-thick-1-1 thick FN rostral BDA app spiking w/et (wide) wisping (est) 
3wk-thick-1-2 thick FN rostral BDA app contact contact 
3wk-thick-1-3 thick ColXII rostral BDA app growth beyond growth beyond 
3wk-thick-1-4 thick ColXII rostral BDA app spiking w/et (wide) wisping (est) 
3wk-thick-1-5 thick GFAP/GS rostral BDA app growth initiation/wrapping wisping (est) 
3wk-thick-1-6 thick GFAP/GS rostral BDA app growth beyond growth beyond 
3wk-thick-1-7 thick GFAP/GS rostral BDA app spiking w/et (wide) wisping (est) 
3wk-thick-2-1 thick TN 3A10 spiking w/et wisping 
3wk-thick-2-2 thick LM 3A10 contact/growth beyond contact/growth beyond 
3wk-thick-2-3 thick LM 3A10 wrapping/wisping wisping 
3wk-thick-2-4 thick CSPG 3A10 wisping wisping 
3wk-thick-2-5 thick TN 3A10 wisping/spiking w/o et spiking w/o et 
3wk-thick-2-6 thick CSPG 3A10 spiking w/et (wide) wisping 
3wk-thick-2-8 thick CSPG 3A10 contact contact 
cellID1-3wk-1 pfn long LM, TN-C, GFAP rostral BDA app, 3A10 wrapping – 
cellID1-3wk-2 pfn long CD11b caudal BDA app, 3A10 wisping wisping 
cellID1-3wk-3 pfn long IB4, GFAP, LM, TN-C rostral BDA app, 3A10 wisping wisping 
cellID1-3wk-4 pfn long FN, ColXII, CSPG caudal BDA app, 3A10 wisping wisping 
cellID1-3wk-5 pfn long FN, CSPG, ColXII, IB4 rostral BDA app, 3A10 wisping/spiking w/o et wisping 
cellID1-3wk-6 pfn long FN, CSPG, ColXII, TN caudal BDA app, 3A10 wrapping/wisping wisping 
cellID1-3wk-7 pfn long LM, TN, GFAP, IB4 rostral BDA app, 3A10 wisping wisping 
cellID1-3wk-8 pfn long LM, TN, GFAP, IB4 caudal BDA app, 3A10 contact contact 
cellID4-3wk-9 cryo long various 3A10 wisping spiking w/o et 
cellID4-3wk-10 cryo long various 3A10 wrapping/wisping wisping 
cellID4-3wk-11 cryo long various 3A10 wrapping/wisping wisping 
cellID4-3wk-12 cryo long various 3A10 wrapping/wisping wrapping 
cellID6-3wk-13 pfn long H&E - contact (est) contact (est) 
cellID6-3wk-14 pfn long H&E - wisping (est) wisping (est) 
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Table S4.1. Continued. 
Exp-Animal Prep Antibody/ Stain Axon Label 
Stage on  
Rostral Side* 
Stage on  
Caudal Side* 
cellID8-3wk-1 pfn long H&E, GFAP/GS - contact (est) contact (est) 
cellID8-3wk-2 pfn long H&E, fibrin, GFAP/GS - wisping (est) wisping (est) 
cellID8-3wk-3 pfn long H&E, fibrin, GFAP/GS - contact (est) contact (est) 
2.5 wk-1-1 pfn long vWF/FN, GFAP/fibrin rostral BDA app, 3A10 wisping wisping 
2.5 wk-1-2 pfn long vWF/FN, GFAP/fibrin rostral BDA app, 3A10 wisping wisping 
2.5 wk-1-3 pfn long vWF/FN, GFAP/fibrin rostral BDA app, 3A10 wisping wrapping 
2.5 wk-1-4 pfn long vWF/FN, GFAP/fibrin 3A10 wisping wisping 
2.5 wk-1-5 cryo long CSPG 3A10 wisping wisping 
2.5 wk-1-6 cryo long CSPG 3A10 wrapping/wisping wisping 
2.5 wk-1-7 cryo long CSPG 3A10 wisping wisping 
2.5 wk-1-8 cryo long CSPG 3A10 wisping wisping 
2.5 wk-1-9 cryo cross CSPG, vWF/FN 3A10 wisping wisping 
2.5 wk-1-10 cryo cross CSPG, vWF/FN 3A10 wisping wisping 
2.5 wk-2-11 pfn long H&E, GFAP, vWF 3A10 wrapping/wisping wrapping/wisping 
2.5 wk-2-12 pfn long H&E, GFAP, vWF 3A10 wisping wisping 
2.5 wk-2-13 pfn long H&E, GFAP, vWF 3A10 wisping wisping 
2.5 wk-2-14 pfn cross GFAP, LM, TN 3A10 wisping (est) wisping (est) 
2.5 wk-2-15 pfn cross GFAP, LM, TN 3A10 wrapping/wisping (est) wrapping/wisping (est) 
2.5 wk-2-16 pfn cross GFAP, LM, TN 3A10 wrapping/wisping (est) wisping (est) 
2.5 wk-2-17 pfn cross FN, ColXII, vWF rostral BDA app wisping (est) wisping (est) 
2.5 wk-2-18 pfn cross FN, ColXII, vWF rostral BDA app spiking w/et (est) wrapping (est) 
2.5 wk-2-19 pfn cross FN, ColXII, vWF rostral BDA app wrapping (est) wisping (est) 
* Stage was estimated (est) if axons were not labeled with BDA or 3A10 or if the tissue was analyzed in cross sections 
(cross). Staging in thick sections (whole-mount) is more reliable than staging in paraffin (pfn) or cryosections (cryo) sections. 
long, longitudinal section; et, ependymal tube; app, application. 
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Table S4.2. Table of other antibodies tested. 
Antigen Antibody Type Company, Cat # Frozen Paraffin Thick Dilution, Format Notes 
Collagen I 
(human) 
goat IgG pAb Santa Cruz, SC-
25974 
✖ - - 1/10, concentrate non-specific labeling 
 
NCAM (chick) mouse IgG1 mAb DSHB, 4D ✖ - - 1/25, 1/5, concentrate no bands on reduced & 
non-reduced WBs 




mouse IgG2a BDTransLab, 
610517 
✔ ✔ ✔ ~1/1500, concentrate labels astros & all processes 
(astros & EG) 
Keratin 18 
(mammalian) 
mouse IgG1 mAb Santa Cruz, SC-
32329 
✔ ✔ - 1/25, concentrate labels EG in intact cord, 
but not regen cord 
vimentin mouse IgM DSHB, 3CB2 ✖ ✖ - 1/50, concentrate tested on intact cord 
 
Sox2 (human) rabbit IgG pAb Abcam, ab15830 ✔ - - 1/>25, concentrate tested on 3wk regen, appears 
to label neurons 
msx 1/2 (chick) mouse IgG1 DSHB, 4G1 ✖ 
(in SCI) 
- - 1/100, ascites tested on 3wk regen, 
no labeling in SCI 
22/18 mouse IgM DSHB, 22/18 ✖ 
(in SCI) 
- - 1/25, concentrate tested on 3wk regen, 
no labeling in SCI 
Isolectin B4-FITC - Sigma, L2895 ✔ ✔ ✔ use at 20 µg/ml labels microglia, meninges, 
and many cells in lesion 
Iba1 rabbit Wako, 019-
19741 
✖ ✖ - 1/500 tested on 3wk regen 
 
Iba1 (human) goat IgG pAb Abcam, ab5076 ✖ - - 1/200, concentrate tested on 3wk regen 
 
OX-42 mouse Serotec, 
Mca275r 
- ✖ - 1/50 tested on 3wk regen 
 
CD11b rat Serotec, 
Mca74ga 
✖ ✖ - 1/100 tested on 3wk regen 
 
CD11b rat BD Pharm, 
550282 
✖ ✖ - 1/50 tested on 3wk regen 
 
F4/80 rat Serotec, Mca497 - ✖ - 1/10 tested on 3wk regen 
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Table S4.2. Continued. 
NG2 rat US Biologicals, 
C5067-70d 
✖ ✖ - 1/500 tested on 3wk regen 
 
NG2 (human) goat IgG pAb Santa Cruz, SC-
30923 (G-20) 
✖ - - 1/25, concentrate tested on 3wk regen 
 
Raldh2 (human) goat IgG pAb Santa Cruz, SC-
22592 (N-20) 
✖ - - 1/25, concentrate tested on 3wk regen 
 
Raldh2 rabbit pAb from P. 
McCaffery via S. 
Scott 
✖ ✖ - 1/100 tested on intact cord 
 
Olig1 (human) goat IgG pAb R&D Systems, 
AF2417 
✖ - - 1/25, concentrate tested on 3wk regen 
 
Olig2 mouse IgG1 Abcam, ab64547 - ✖ - 1/2000, ascites tested on 3wk regen 
 
Olig mouse IgG DSHB, Olig ✖ ✖ - 1/25, concentrate tested on intact cord 
 
MAG (chick) mouse IgG1 mAb Chemicon, 
MAB1567 (513) 
✔ ✖ ✖ 1/100, concentrate  
 
MAG mouse mAb from R. Quarles 
via M. Filbin 
✖ - - 1/50 tested on intact cord 
 
Nogo-A (human) rabbit pAb Santa Cruz, SC-
25660 (H-300) 
✖ - - 1/25, 1/10, concentrate  
 
P0 rabbit pAb from M. Filbin ✔ - - 1/50 tested on intact cord, 
strong label in PNS, 
weak label in CNS that 
may be non-specific, 
multiple bands on WB 





4.8 Movie legends 
 
Movie 4.1. Recovery of swimming function after spinal cord transection 
injury. When an uninjured newt swims, it propels itself forward by 
pressing its legs close to its side and undulating its body in an S-shaped 
motion. When it is finished swimming, it brings its legs forward again, 
perpendicular to its body axis. One day after a complete transection injury, 
the hindlimbs are completely paralyzed. Four weeks after injury, this same 
newt is still paralyzed. When it attempts to swim, it does not use its 
hindlimbs at all. By 7 wks, this newt has recovered swimming function 
and swims similarly to an uninjured newt. 
 
Movie 4.2. Movie through confocal z-stack of animal shown in Figure 
4.5D, a wisping/spiking stage regenerate. The movie begins on the ventral 
side of the cord and moves in 2 µm increments through to the dorsal side. 
Rostral is up. Axons are labeled with 3A10 in magenta, and nuclei are in 
green. Note the meninges appear to have regenerated across the gap first 
and that some axons appear to have followed these meninges.  
 
Movie 4.3. Movie through confocal z-stack of animal shown in Figure 
4.2J, a spiking stage regenerate. The spike does not contain an ependymal 
tube in this animal. The movie begins on the ventral side of the cord and 
moves in 2 µm increments through to the dorsal side. Rostral is up. 
Descending axons are labeled with the axon tracer in magenta and nuclei 
are in green.  
 
Movie 4.4. Movie through confocal z-stack of animal shown in Figure 
4.2I, a spiking stage regenerate. The spike does contain an ependymal tube 
in this animal. The movie begins on the ventral side of the cord and moves 
in 2 µm increments through to the dorsal side. Rostral is up. Descending 
axons are labeled with the axon tracer in magenta and nuclei are in green.  
 
Movie 4.5. Movie through confocal z-stack of animal shown in Figure 
S4.4A-A”, a recovered animal. This is a 9 wk regenerate in the growth 
beyond stage that had recovered function. The movie begins on the ventral 
side of the cord and moves in 2 µm increments through to the dorsal side. 
Rostral is up. Descending axons are labeled with the axon tracer in 




Movie 4.6. Movie through confocal z-stack of animal shown in Figure 
S4.4E, a nonrecovered animal. This is a 9 wk regenerate in the growth 
beyond stage that had not recovered function. It begins on the ventral side 
of the cord and moves in 2 µm increments through to the dorsal side. 
Rostral is up. Descending axons are labeled with the axon tracer in 
magenta and nuclei are in green. Note there are two ependymal tubes on 
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The broad aim of this dissertation was to add to our understanding of how 
naturally occurring regenerative processes take place so that, one day, we may know how 
to stimulate those regenerative processes in our own species. I used the newt as a model 
system because it represents the vertebrate with the most extensive regenerative abilities 
in its adult form. The newt also has the advantage that, unlike fish, it is a tetrapod. Work 
presented herein focuses mainly on spinal cord regeneration, but also touches on limb 
regeneration. In Chapter 2, I presented data suggesting that a novel newt chemokine may 
have a role in stimulating cell proliferation and migration after limb amputation, and thus, 
may have a role in the formation and growth of the regeneration blastema. In Chapter 3, I 
demonstrated how whole-mount fluorescent labeling and imaging techniques were 
adapted for use in the newt spinal cord. This method greatly improved our ability to 
visualize the cellular and extracellular environment and understand 3-dimensional 
relationships in the intact and injured cord. In Chapter 4, I used the new methods to 
identify stages of axon regeneration after a complete transection spinal cord injury (SCI) 
to the lower trunk region of the animal and found that axons appear to be able to 
regenerate through the lesion, in part, because the environment permits axon 
regeneration. This is in contrast to what is already known to occur in the injured 
mammalian spinal cord, where the environment is inhibitory for axon regeneration.  
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5.1 Models of spinal cord regeneration 
After an SCI in the newt, meningeal and endothelial cells migrate into the lesion 
before axons do and are associated with a loose extracellular matrix (ECM) that permits 
axon regeneration. Axons regenerate into the lesion next and are closely associated with 
meningeal cells and glial processes. An ependymal tube lined by glial cells extends into 
the lesion last. Then the meningeal cells, axons, and glia move as a unit to close the gap 
in the cord. Because meningeal cells and glia appear to assist axon regeneration rather 
than form barriers, such as a glia limitans and dense scar, I hypothesize that this is a 
primary reason why regeneration is successful in the newt. Endothelial cells are not as 
closely associated with regenerating axons as the meningeal cells and glia, but they may 
assist axons by providing trophic support and/or by contributing to the formation of the 
permissive ECM. Phagocytic cells and leucocytes are also present in the lesion, and these 
may assist axon regeneration by clearing debris and releasing factors that stimulate 
beneficial cellular responses. 
Newt spinal cord regeneration after an SCI differs from that after tail amputation 
(Nordlander and Singer, 1978; 1983) in that axons precede the ependymal tube into the 
lesion rather than vice versa. Thus, an ependymal tube is not required to provide a 
scaffold for axon regeneration. Instead, meningeal cells and glial processes may fill this 
role. Spinal cord regeneration after an SCI may also be different between the newt and 
axolotl in that unlike axolotl ependymoglia (EG), newt EG do not appear to undergo a 
massive epithelial to mesenchymal transition and fill the injury site with cells that re-
epithelialize to form an ependymal tube which then supports axon regeneration (O'Hara 
et al., 1992; Chernoff et al., 2003). On the other hand, it is possible that events after an 
 172 
SCI in the axolotl are actually similar to those after an SCI in the newt, and these events 
were interpreted differently by the investigators. For example, the GFAP-, FN+ cells in 
the injury site that they identified as EG could have been meningeal cells. Regeneration 
after an SCI in the eel appears to proceed similarly to that in the newt (Dervan and 
Roberts, 2003). The authors described the bridge of tissue across the lesion as consisting 
of “regrowing axons enwrapping a central canal and enclosed in a meningeal sheath.” 
They also note that axons grow into the lesion before the ependymal cells elongate a 
central canal. Regeneration after an SCI in zebrafish or frog tadpoles has not been 
examined at this level of detail. It will be interesting in the future to do comparative 
analyses between regeneration-competent and regeneration-incompetent animals to 
determine which factors and events are common to successful spinal cord regeneration 
and which are common to regeneration failure. For example, events after SCI in 
zebrafish, goldfish, lamprey, eel, axolotl, newt and frog tadpole could be compared to 
those in the regeneration-incompetent lizard and adult frog. Given that cold-blooded 
animals have a greater regenerative capacity than warm-blooded animals, it would also 
be interesting to determine if the naked mole rat, a mammal that has re-gained cold-
bloodedness, has a greater regenerative capacity than mice and rats.  
5.2 Implications for spinal cord regeneration in mammals 
Now that we know more about the cellular and extracellular responses to SCI in 
the newt, we can compare them to those in mammals and begin to consider why these 
differences exist and how they may guide future strategies in regenerative medicine. 
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 In both newts and mammals, initially after an SCI, axons retract from the end of 
the cut cord and appear dystrophic. This indicates that axon retraction does not preclude 
successful regeneration. Instead, it may even promote neuronal survival. The acute injury 
site may be harmful to axotomized neurons, and the axotomized neuron may need time to 
mount an intrinsic regenerative response before traversing the injury site. Therefore, 
instead of seeking ways to prevent axon retraction in mammals, it may be more useful to 
discover how to activate intrinsic growth potential. A recent study deleted the tumor 
suppressor gene, phosphatase and tensin homolog (PTEN), in mouse corticospinal 
neurons, and this enabled them to regenerate axons across a transection SCI (Liu et al., 
2010). This regeneration, however, was not sufficient to restore function and was only 
seen at the edges of the cord. It would be interesting to determine if the intrinsic growth 
potential of newt neurons is activated by a similar mechanism and what the downstream 
effects of activation are. For example, receptors that mediate inhibition may be 
downregulated (Keleman et al., 2002), internal levels of cyclic nucleotides may be 
increased (Cai et al., 2001; Qiu et al., 2002), and expression of proteins that promote 
growth cone motility may be upregulated, such as integrin β1 and MMPs (Condic et al., 
1999; Condic, 2001; Hayashita-Kinoh et al., 2001). These questions can be partially 
answered with expression studies, but to test the requirement for or sufficiency of various 
factors, it would be useful to have a robust system for growing newt neurons in vitro, as 
well as genetic tools for manipulating gene expression in vivo. These tools are not 
currently available for the newt model system and will be discussed more fully below. 
Learning more about how the intrinsic growth potential of newt neurons is activated may 
enable us to more fully activate growth in mammalian neurons. 
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Once growth is initiated, newt axons appear to be able to overcome inhibitory 
factors, such as chondroitin sulfate proteoglycans (CSPGs), in their environment. Their 
environment, however, does not present physical barriers to regeneration. I hypothesize 
that if such barriers were created, then newt axons, like mammalian axons, would not be 
able to regenerate across the lesion in sufficient numbers to restore function. To address 
this issue, I attempted to make the newt SCI site more inhibitory by adding CSPG protein 
or by blocking matrix metalloproteinase (MMP) function with the drug GM6001. These 
studies were inconclusive, however, because I was never able to demonstrate that the 
manipulation affected the nature of the lesion ECM. Similar experiments have been more 
successfully attempted in the optic nerve of frog tadpoles (Reier et al., 1983) and in the 
spinal cord of goldfish (Bernstein and Bernstein, 1967). In these experiments, axons were 
able to regenerate through the “glial scars” that were created, but it is unclear how similar 
these scars are to those that are formed in mammals. These studies also did not assess 
functional recovery nor did they determine if axons emerged from the scar to penetrate 
the optic nerve or spinal cord on the opposite side of the scar. While these studies suggest 
that intrinsic growth potential is likely vital for successful regeneration, they also indicate 
that regeneration is suboptimal if there are barriers in the environment. Indeed, if the two 
ends of the newt spinal cord are misaligned, functional recovery does not occur (Davis et 
al., 1990; see also Chapter 4). The misalignment, in effect, creates a physical barrier to 
regeneration. Thus, it may be fruitful to develop strategies in mammals that induce cells 
to create a pathway for axon regeneration rather than barriers. If we can combine such 
strategies with those that induce intrinsic growth potential, such as the PTEN-deletion 
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strategy used in the study mentioned above (Liu et al., 2010), then we may be able to 
induce functional spinal cord regeneration in mammals.  
After an SCI in mammals, meningeal cells and glia create physical barriers in 
order to wall off the area and re-establish the blood brain barrier (BBB) (Silver and 
Miller, 2004). This serves to minimize the extent of the injury. For example, when 
reactive astrocytes are ablated from a mouse SCI site, the BBB is not repaired, the 
inflammatory response is elevated, there is more cell death, and functional deficits are 
more severe (Faulkner et al., 2004). In contrast, newt meningeal cells and glia do not 
appear to wall off the injury site, at least not as aggressively as their mammalian 
counterparts. How is the BBB repaired in the newt? How long does it take? I would 
predict that the BBB is repaired more slowly in the newt. This can be tested by injecting 
molecules into the blood stream that cannot cross the BBB (such as rhodamine-bovine 
serum albumin) and then assessing how long after injury these molecules are able to leak 
into the nervous tissue (Tennant and Beazley, 1992). The consequences of prolonged 
BBB disruption may be more severe in warm-blooded animals, and this may explain why 
mammalian astrocytes and meningeal cells evolved such strong reactions to central 
nervous system (CNS) injuries. It will be important to understand the differences in the 
mechanisms of BBB repair between newts and mammals as well as how the dynamics of 
BBB permeability differentially affect the extent of secondary damage if we are to 
discover a way to effectively remove the barriers to regeneration in mammals. 
This may make finding therapies in mammals using information gleaned from 
newts a challenging endeavor. Nonetheless, there are hints that mammalian cells may 
retain the capacity to respond to an SCI in ways that support axon regeneration, similar to 
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the way newt cells do. When PTEN is deleted from mouse corticospinal neurons, the 
axons regenerate across an SCI lesion in association with GFAP+ processes (Liu et al., 
2010). These GFAP+ “bridges” are found at the edges of the spinal cord. In other words, 
they are found in regions that are closest to the meninges. Thus, mammalian astrocytes 
and meningeal cells may be able to cooperate to form these bridges. It would be 
interesting to determine if these bridges always form or if they only form when axonal 
growth potential is activated. If the latter is true, this would suggest that axons themselves 
have a role in directing cell behaviors at the injury site and would be consistent with 
results seen in the frog tadpole studies mentioned above. When axons grew into an 
implanted glial scar, the hypertrophic astrocytes within the scar adopted a more 
permissive architecture (Reier et al., 1983). Learning more about who the cell players are 
in the newt, where they come from and what roles they play may help us learn how to 
cultivate those types of behaviors in mammalian cells. To do this, however, we will need 
to develop more tools for the newt model system.  
5.3 Tools needed for the newt model system 
5.3.1 Basic tools 
Basic tools, such as newt specific antibodies and mRNA in situ hybridization 
probes, should be relatively simple to develop. These would allow us to identify, classify 
and characterize newt cell types better than before and determine which cells express 
transcripts or proteins that might have a role in shaping the environment or directly 
stimulating, supporting, or guiding axon regeneration. More markers are needed that can 
specifically identify EG, astrocytes, meningeal cells, de-differentiated cells, inflammatory 
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cells, microglia, oligodendrocytes, oligodendrocyte precursor cells, and neurons. Proteins 
of interest, and transcripts encoding those proteins, would include ECM proteins, cell-cell 
and cell-ECM adhesion proteins, cell-cell signaling proteins, MMPs, guidance cues and 
their receptors, and growth factors and their receptors. 
5.3.2 Computational molecular phenotyping 
Computational molecular phenotyping (CMP) may also be useful for 
characterizing cell types in the newt. This method classifies cells based on their relative 
expression of small molecules and metabolites like glutamate, glycine, and glutathione 
(Marc et al., 1995). Because these small molecules are invariant between species (newt 
glutamate is the same as mouse glutamate), the probes used are not species specific. 
Preliminary evidence suggests that CMP will be useful for characterizing the cell types 
present in the intact newt spinal cord, cellular responses to injury, and for interspecies 
comparative analyses, but that it may not be useful for identifying reactive cell types 
present in the middle of an SCI lesion (Odelberg lab, unpublished observations). After an 
SCI, cells in the lesion tend to adopt the same, bland profile of small molecule expression 
and could not easily be separated into classes or correlated with classes that were present 
in the intact cord. This may occur because cells in the lesion have dedifferentiated to a 
progenitor-like state as they do after limb amputation or because the cells lose their 
unique signatures after being disrupted and activated by the injury. 
5.3.3 Neuronal culture system 
As mentioned above, the development of a robust neuronal culture system would 
also greatly add to our understanding of the requirements for and mechanisms of axon 
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regeneration in the newt. I tried to develop such a system, using methods informed by the 
literature (Olsen and Bunge, 1986; Ferretti and Brockes, 1988; Wetzel et al., 1989; 
Chernoff et al., 1990; Benraiss et al., 1996; Tonge et al., 1997; Tonge et al., 1998; Becker 
et al., 1999; Bauduin et al., 2000; Tonge and Leclere, 2000; Ikegami et al., 2002; 
Dmetrichuk et al., 2005), but I was unable to find a system that would reliably allow newt 
neurons or explants to attach to the dish or grow healthy neurites with growth cones. 
Table 5.1 shows what parameters I tried and which appeared to work the best. Given how 
well newt neurons grow axons in vivo, it was surprising that they did not grow neurites 
very well in vitro. Mature, adult neurons, however, are typically harder to culture than 
developing, young neurons. Also, most media/supplement systems available have been 
optimized for warm-blooded, developing mammalian neurons and not cold-blooded, 
adult, amphibian neurons. It is likely the two types of neurons have different 
requirements. 
5.3.4 Genetic tools 
 Clearly, the newt’s regenerative capacities make it an intriguing model system. 
The mechanisms governing its regenerative processes have been very difficult to dissect, 
however, because there are very few tools available for perturbing or following these 
processes.  
Occasionally, a drug inhibitor will produce useful results. The MMP inhibitor, 
GM6001, alters limb regeneration when applied to the water in which the animal swims 
(Vinarsky et al., 2005). AraC, a proliferation inhibitor, is effective at blocking 




Table 5.1. Parameters tested for the development of a newt neuronal cell culture system 







dissociated & explant 
spinal ganglia explant 
CNS explant,  
preconditioned,  
with meninges left on 
dissociation 
collagenase & dispase 
0.25 – 0.05% trypsin 
10 min – 100 min 
with or without DNase 
0.125% trypsin, 100 min 
with DNAse  
purification 
preplate 
cell strainer & centrifugation 
percoll gradient 
unpurified 
















*but attachment is poor* 
(if more attached,  




or meningeal cells 
medium 
(adjusted to  







all about the same, 








newt galectin & chemokine 
serum 
NGF & NT3 growth factors 
all about the same  
 180 
manually injected into cells to follow their fate after injury (Lo et al., 1993; Echeverri et 
al., 2001), but these markers are not permanent and not all cell types are amenable to this 
type of analysis.  
The ideal and most versatile way to manipulate biological function is with genetic 
tools. The newt is not a very practical model system for transgenic experiments because 
newts require 3 to 5 years to become sexually mature adults, and a system for breeding 
them in the lab has not been developed. Newts used in laboratory experiments are 
collected from the wild. Plasmids have been used for gain-of-function experiments 
(Kumar et al., 2007) and to express fluorescent tags (Echeverri and Tanaka, 2002), but 
expression is only transient and electroporation must be used to allow the plasmid to 
enter cells. This can complicate results because electroporation itself has been shown to 
cause a cellular response. Namely, it causes cells to de-differentiate (Atkinson et al., 
2006). Morpholinos work with only limited efficiency in vivo in the axolotl (Schnapp and 
Tanaka, 2005) and do not appear to be effective in the newt (Odelberg lab, unpublished 
observations). Morpholinos also require electroporation to enhance their efficacy. 
Viral vectors, especially lentiviral vectors, may be the best option for 
manipulating gene expression in adult newt tissues. Lentiviral vectors can integrate in the 
genome of dividing and non-dividing cells to produce stable changes in gene expression. 
This is advantageous for regenerative processes that occur over the course of weeks to 
months. Lentiviral vectors can be used for overexpression/gain-of-function as well as 
loss-of-function/RNA interference studies (Szulc et al., 2006; Szulc and Aebischer, 
2008). Lentiviral and retroviral vectors pseudotyped with the VSV-G envelope protein 
are able to induce expression of reporter proteins in newt cell lines in vitro (Kumar et al., 
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2000; and unpublished observations), but do not appear to be effective when injected in 
vivo (unpublished observations). When lentivirus was added to newt muscle or blastemal 
cell lines at a multiplicity of infection of 1000, 47% and 100% of the cells, respectively, 
expressed low levels of the enhanced green fluorescent protein (EGFP) reporter (driven 
by the CMV promoter) when analyzed via fluorescence-based flow cytometry 5 days 
after transduction. When 1 µl of the lentivirus (titer 8 x 108 infection-forming units/ml) 
was injected into intact and regenerating newt limbs, EGFP expression could not be seen 
in whole limbs. This is not because it is impossible to see EGFP expressed in whole 
limbs. EGFP expression driven by the CMV promoter can be seen in whole limbs when 
expressed from electroporated plasmids (Atkinson et al., 2006). Either the virus is unable 
to readily enter newt cells, or the virus enters the cells and integrates into the genome but 
is silenced. This is worth further investigation. There are viruses that infect newts 
(Larsen, 1969; Balseiro et al., 2009). Discovering what envelope protein(s) these viruses 
use to gain entry into newt cells may enable us to develop a viral tool that can transduce 
newt tissues more efficiently. 
Until versatile genetic tools are available for use in the newt, we will be unable to 
definitively answer many questions about what factors stimulate and direct cell 
behaviors, what factors are required for a given process, or which cell lineages give rise 
to reactive or new cell types. It will also be very difficult to determine what roles 
candidate genes identified via microarray and expression analyses, such as the novel newt 
chemokine discussed in Chapter 2, play during regeneration. Finally, if the newt can be 
transformed into a model system amenable to genetic manipulations, it will be 
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advantageous to sequence its genome and establish a facility to raise newts for laboratory 
studies, so that natural populations are not depleted.  
5.4 Alternative model systems 
An alternative, or complementary, strategy for learning more about the 
mechanisms of regeneration is to translate findings in the newt to model systems that are 
already more amenable to genetic manipulations, such as the axolotl or zebrafish. Though 
axolotl tissues may be less mature than newt tissues and zebrafish do not have four limbs, 
regenerative pathways in these organisms are likely to be similar to those in the newt. 
The advantage of being able to probe their biology more deeply outweighs the 
disadvantage of them being less similar to an adult mammal. Axolotls and zebrafish are 
bred for lab use, they develop faster, and transgenic lines are available. Axolotls are 
transparent enough for in vivo imaging, and it is therefore possible to observe cellular 
events at multiple time points in the same animal. The zebrafish is a well-established 
model system, much is known about its developmental biology, mutant lines are 
available, protocols have been developed for many techniques, morpholino tools are 
available, and its genome has been sequenced (Becker and Becker, 2007).  
5.5 Summary 
 Regeneration is a fascinating and challenging subject, and the regenerative 
abilities of the newt give us hope that it may be possible to stimulate limb and spinal cord 
regeneration in humans. While we are still a long way from achieving this goal, the work 
presented in this dissertation has taken us one step closer. We have more methods for 
analyzing newt tissues. We now know that a chemokine may play a role in stimulating 
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cells to proliferate and migrate to form the regeneration blastema, the self-organizing 
structure capable of directing epimorphic regeneration of limbs and tails. We also now 
have a clearer picture of the cellular events and the extracellular environment associated 
with spinal cord regeneration after an SCI. Spinal cord regeneration appears to be 
enabled, in part, because the environment is permissive for axon regrowth. Meningeal 
cells and glia appear to play an important role in creating this permissive environment. 
Future experiments can test these hypotheses, when more tools become available. These 
hypotheses also hint that it may be fruitful to look for ways to alter meningeal cell and 
glial responses in spinal cord injured mammals so that they are more like those in the 
newt.  
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